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1 ABSTRACT 
 
 
First part of this thesis dealt with the potential of human adult stem cells PSC and MSC to 
differentiate in epithelial- and endothelial-like cell types. Before starting differentiation 
experiments, PSC as a new source of stem cells, were analyzed for their endogenous 
expression profile of endothelial, epithelial and stem cell markers. Changes in expression 
profile induced by various matrices, changes in morphology during air-interface culture and 
generation of organoid bodies were also determined. For provoking endothelial 
differentiation, stem cells were incubated on different surfaces and with various combinations 
of bFGF and VEGF. Both cell types showed already an immanent endothelial potential, 
which was not enhanced by the applied protocols. Epithelial differentiation was initiated by 
coculture with the epithelial cell lines A549 and Calu-3 in either direct or indirect contact or 
in a combination. Not only type of coculture but also choice of epithelial cell type had a 
partially contrary influence on the expression of CDH-1.  
Second part of this thesis monitored changes in ZO-1 isoform ratio in Caco-2, T84, Calu-3, 
A549 and PSC. There existed no correlation to proliferation, cell number and density, TEER 
or expression of occludin. However, for the first time it was observed that ZO-1 isoform ratio 
was not constant but varied in nearly all cell types. In Caco-2 there was even a complete turn-
over observed, which correlates with proceeding functional differentiation. 
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2 KURZZUSAMMENFASSUNG 
 
 
Im ersten Teil der vorliegenden Arbeit wurden endotheliales und epitheliales 
Differenzierungspotential der humanen adulten Stammzellen PSC und MSC untersucht. Da es 
sich bei PSC um eine sehr neue Stammzellquelle handelte, wurden diese zunächst genau 
hinsichtlich ihrer bereits innewohnenden endothelialen, epithelialen und auch 
Stammzellmerkmale charakterisiert. Um eine endotheliale Differenzierung zu erreichen 
wurden die Stammzellen auf verschiedenen Oberflächen mit unterschiedlichen 
Kombinationen von bFGF und VEGF inkubiert. Keines der angewendeten Protokolle war in 
der Lage eine weitergehende Expression endothelialer Marker zu bewirken. Für die 
epitheliale Differenzierung wurden die Stammzellen mit den Lungenzelllinien A549 und 
Calu-3 cokultiviert. Dies geschah entweder in direkter oder indirekter Cokultur oder in einer 
Kombination. Nicht nur der verwendete epitheliale Zelltyp sondern auch die Art der Cokultur 
hatte einen teilweise gegensätzlichen Einfluss auf den Marker CDH-1.  
Im zweiten Teil wurden Änderungen im ZO-1-Isoformverhältnis in Caco-2, T84, Calu-3, 
A549 und PSC beobachtet. Das bisher als fix postulierte Verhältnis variierte über die 
Kulturdauer in fast allen Zellarten. Eine Korrelation zu Proliferation, Zellzahl und -dichte, 
TEER oder Occludinexpression gab es nicht. Bei Caco-2 jedoch wurde sogar eine komplette 
Umkehr des Verhältnisses beobachtet, die einher ging mit der voranschreitenden funktionalen 
Differenzierung. 
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3 ABBREVIATIONS 
AIF Air Interface Culture 
AJ Adherens Junctions 
APN Aminopeptidase  
bFGF  Basic Fibroblastic Growth Factor 
BrdU 
BSA 
5’-Bromo-2’-deoxy-uridine 
Bovine Serum Albumine 
C I Collagen I 
C IV 
CD 
Collagen IV 
Cluster of Differentiation 
CDH 1  Cadherin 1 
COPD   Chronic Obstructive Pulmonary Disease 
DM Differentiation Medium 
EB Embroid Bodies 
ECM Extracellular Matrix 
(h)ESC  (human) Embryonic Stem Cell 
ECGM Endothelial Cell Growth Medium 2  
EMT Epithelial to Mesenchymal Transitions 
FACS Fluorescence Activated Cell Sorting 
FBS Fetal Bovine Serum 
FN Fibronectin 
hAEpC Human Alveolar Epithelial Cells  
HUVEC  
ICM 
iPS 
Human Umbilical Vein Endothelial Cells 
Inner Cell Mass 
Induced Pluripotent Stem Cells 
LN Laminin 
MSC Mesenchymal Stem Cell 
OB Organoid Body  
PBS  
(RT-) PCR  
Phosphate Buffered Saline 
(Reverse Transcriptase-) Polymer Chain Reaction 
PDL Poly-D-Lysine 
PET Polyethylene Therephtalate 
PM Primary Medium 
PSC 
RFI 
Pancreatic Stem Cells 
Relative Fluorescence Intensity 
RT 
SDS-PAGE 
Room Temperature 
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis 
TCP Normal Tissue Culture Plastic  
TEER  Transepithelial Electrical Resistance 
TJ Tight Junction 
VCAM 1  Vascular Cell Adhesion Molecule 1 
VEGF  Vascular Endothelial Growth Factor 
VEGFR VEGF Receptor 
vWF von Willebrand Factor 
ZO Zona Occludens 
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4 MOTIVATION 
Differentiation in biology is defined as a process by which a less specialized cell undergoes a 
change to a more specialized cell type. This process dramatically changes a cell's size, shape, 
membrane potential, metabolic activity, and responsiveness to signals. These changes are 
largely due to highly controlled modifications in gene expression.  
Differentiation is pivotal during ontogenesis, when the zygote becomes an embryo with many 
specialised cell and tissue types. But also in the adult organism differentiation takes place in 
many different cell types. First of all there is the differentiation of adult stem cells. They serve 
as the body’s own maintenance and repair system. They divide and create daughter cells for 
use in normal cell turn over and tissue damage. Moreover, the term differentiation comprises 
the further functional specialisation of already dedicated somatic cells. This thesis was 
interested in both aspects. 
 
Directed differentiation of adult stem cells is of great interest for medical and pharmaceutical 
research. Stem cells from a patient could generate cells, tissues and organs for later 
transplantation without risk of rejection. Furthermore, autologous stem cells could 
differentiate into target cells for individual drug response studies in vitro. Primary endothelial 
cells can not be harvested and expanded in sufficient amounts to serve this purposes. Thus, 
ndothelial cells generated by stem cells could be used for covering vascular prostheses and for 
repairing injured vessels and ischemic tissues. Lung epithelial cells produced from stem cells 
are of interest for in vitro transport studies and cytotoxicity testing. So far established cell line 
models of the lung epithelium are not optimal.  
For these purposes human adult stem cells have to be identified, which are able to 
differentiate reproducibly into the desired lineages. PSC and MSC are two such possible 
sources with auspicious properties. In 2004 PSC were described for the first time and had a 
promising start as pluripotent stem cells. They showed their potential by spontaneously 
differentiating into cell types from all three germ layers [1]. MSC on the other hand are 
already established in clinical therapies, where they are so far the sole approved source of 
stem cells. They have shown to differentiate into multiple lineages and also pluripotency has 
been reported [2]. Hitherto there have been no established methods to differentiate any stem 
cell type into endothelial or lung-epithelial lineage. Development of adequate approaches was 
therefore aim of this thesis. Additionally, a purposeful characterization of PSC had to be 
performed, since no evaluation of immanent endothelial and epithelial properties of these 
stem cells had been carried out before. 
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The human colon carcinoma cell line Caco-2 exhibits the particular ability to undergo 
spontaneous differentiation to small intestinal enterocyte-like cells. Due to extensive 
morphological and biochemical analogy Caco-2 are widely used as a small intestinal model in 
toxicity testing and transport studies. Functional differentiation of Caco-2 is usually 
monitored by increasing activity of brush border enzymes. During preceding experiments of 
our cooperation partner, the Department of Biochemistry at the University of Pavia, Italy, it 
was discovered that the amount of ZO-1 isoforms varied considerably during differentiation 
of the somatic cell line Caco-2. ZO-1 is a protein found mainly in tight junctions of 
epithelium and endothelium. It combines a structural role as a cell adhesion protein with a 
regulatory role by modulating cell proliferation. ZO-1 is expressed in two isoforms, α+ and α-, 
whose function could not be clarified yet. Ratio of the two isoforms was so far considered 
constant and thus characteristic for a certain cell type. A shift in expression of the two ZO-1 
isoforms has not been reported before, neither for Caco-2 nor for any other cell type. Aim of 
this study was, in cooperation with Pavia, to address the question whether this observation 
was related to any other parameters. Therefore, expression of ZO-1 isoforms was monitored 
in parallel to cell number, cell density, proliferating activity, TEER value and expression of 
occludin, a further tight junction protein and to functional differentiation of Caco-2. For 
determining whether the change in isoform expression was peculiar for Caco-2 6 cell types 
were investigated: T84 as a further model of an intestinal cell line, A549 and Calu-3 as a lung 
epithelial model, ECV304 representing endothelium and PSC as primary stem cells.  
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5  PSC AND MSC - TWO SOURCES OF HUMAN ADULT STEM CELLS 
AND THEIR EPITHELIAL AND ENDOTHELIAL POTENTIAL 
 
 
Parts of this section have been published in: 
 
Meier, K., C.M. Lehr, and N. Daum, Differentiation potential of human pancreatic stem cells 
for epithelial- and endothelial-like cell types. Ann Anat, 2009. 191(1): p. 70-82 [3] 
 
 
 
5.1 INTRODUCTION 
5.1.1 GENERAL TERMS AND DEFINITIONS 
The term “Stem Cell” has been coined for the first time in 1908 by the Russian histologist 
Alexander Maksimov. At a congress of the Hematologic Society in Berlin he postulated the 
existence of stem cells on which he built his model of hematopoiesis. The usage of this term 
lay nearly idle until the 1960s, when the two Canadian researchers McCulloch and Till found 
self renewing cells in mouse bone marrow [4, 5]. Roughly 20 years later, in 1981 
simultaneously two groups of researchers one in San Francisco, USA, around Gail Martin, 
and one in Cambridge, UK, around Martin Evans and Matthew Kaufmann, discovered 
techniques for extracting stem cells from mouse blastocysts [6, 7]. And it was Gail Martin to 
whom the term “Embryonic Stem Cell” was attributed. Thus, the existence of the two broad 
types of mammalian stem cells has been asserted: adult and embryonic stem cells (for other 
types of stem cells see Chapter  5.1.4) 
Adult stem cells are present in tissues all over the body throughout the whole lifetime of an 
organism. Embryonic stem cells (ESC), however, are defined by their origin and are therefore 
only isolated from the inner cell mass of blastocysts. Apart from their origin both types of 
stem cells differ also considerably in their abilities and their applications. However, both of 
them display the combination of two properties, which accounts for the definition of a stem 
cell: self renewal and potency.  
Long-term self renewal is the ability to go through numerous cycles of cell division (self 
replication) while maintaining an undifferentiated state. Stem cells undergo two different 
types of cell division to ensure this property (Figure 1). A symmetric division yields in two 
identical daughter cells, which both display stem cell properties. An asymmetric cell division 
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produces two different daughter cells. One of them is a stem cell and the other a progenitor 
cell. These cells have a limited self-renewing potential and undergo several rounds of 
symmetric cell division until they finally differentiate into one defined mature cell type. 
symmetric                            assymetric
Stem cell
progenitor cell
 
Figure 1: Symmetric and asymmetric division of stem cells. 
 
The ability to give rise to specialized cell types is called potency. Depending on the kind and 
the number of different mature cell types a stem cell can differentiate into, certain definitions 
of potency have been established.  
Totipotent or omnipotent cells can give rise to embryonic and extraembryonic cell types and 
can therefore build up a whole, viable organism. Only cells from the first few divisions of a 
fertilized egg have this ability.  
Pluripotent stem cells can give rise to cell types from all three germ layers and thereby 
construct nearly any tissue of the body. Embryonic and also few types of adult stem cells 
display this property. 
Multipotent cells can differentiate into more than one cell type. The cells they give rise to are 
usually closely related and originate from the same germ layer. Haematopoietic stem cells are 
a typical representative for multipotent cells 
Oligopotent cells (e.g. lymphoid stem cells) can differentiate into few cell types of a certain 
tissue. 
Unipotent cells can give rise only to one cell type (e.g. fibroblasts).  
Defining the different categories of potency also the term plasticity has to be elucidated. 
Plasticity (also called transdifferentiation) is the ability of tissue-specific stem cells to give 
rise to cell types of other tissues, even from other germ layers. 
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5.1.2 EMBRYONIC STEM CELLS 
Embryonic stem cells (ESC) are – as their name suggests – derived from embryos and that at 
the stage of the blastocyst. In human development this stage is reached after 4 to 5 days after 
fertilization. The blastocyst then includes three structures. The trophoblast is a layer of cells 
which surrounds the hollow cavity of the blastocoel. The group of cells at one end of the 
blastocoel, that develops into the actual embryo, is the inner cell mass (ICM). ESC are 
isolated by transferring cells from the ICM to culture dishes where they are usually grown in 
the presence of bovine serum and on a feeder layer. This feeder layer consists of growth-
arrested mouse fibroblasts, which provide ESC with essential growth factors. Without optimal 
culture conditions, ESC are prone to rapid differentiation. When they have the possibility to 
clump together, they easily form embroid bodies (EB) in which they begin to differentiate 
into cell types from tissues of all three germ layers, thereby demonstrating their pluripotency. 
As this process is spontaneous there is no possibility to control the way of differentiation. To 
yield mature specialized cells for application in research and medical treatment, protocols for 
a directed differentiation of ESC have been established. Amongst others ESC so far have been 
differentiated to neural [8, 9], cardiac [10, 11], endothelial [12], haematopoietic [13, 14], 
pancreatic [15, 16], bone [17] and hepatic cell types [18, 19].  
Pluripotency and the nearly indefinite capability of self-renewal make ESC a promising tool 
for regenerative research and medicine. However, there are several arguments opposing the 
application of ESC.  
First of all there is the ethical discussion, as harvesting ESC requires the destruction of a 
human embryo. Although this happens in the early state of the blastocyst, there is a fervid 
discussion about the beginning of life and also its sanctity. Stem cell laws all over the world 
vary significantly by country. In the USA no federal law has ever been adopted, which bans 
the research with hESC. However, several states prohibit the creation or destruction of a 
human embryo for medical research. Laws in the European Union vary from the allowance to 
destroy human embryos for clinical purposes (UK) to the exclusive application of imported 
stem cell lines (Germany).  
Even more drawbacks apply, when ESC or ESC-derived cells are to be injected or 
transplanted into a human body. As cells and tissues derived from ESC are “foreign” for the 
host body, the immune system of the host will inevitably try to reject the transplant. Although 
thorough choice of donor cells can reduce the reaction of the host body, application of 
immunosuppressive drugs will still be required. Additionally triggered is the immune 
response by non-human molecules, so called xeno-molecules, which adhere to the implanted 
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cells. These molecules come in contact with ESC during their isolation, expansion and 
differentiation, when ESC are in general cultured with mouse feeder-layers and with animal 
sera in the growth medium. However, during the last years some protocols have been 
described which allow the cultivation of hESC either without animal serum [20] or without a 
feeder layer [21]. These protocols may after combination and establishment eliminate the risk 
coming from contamination with xeno-molecules. 
Furthermore to mention is potential cancerogenity of ESC. When ESC are injected or 
implanted, they are prone to form teratocarcinomas in mice [20, 21]. This is due to a non-
complete differentiation into mature cells. In fact there are no protocols, which lead to more 
than 80% differentiated cells. However, just one undifferentiated cell may after application 
lead to a cancerous tumour in the host body. 
Genetic instability and chromosomal abnormalities after prolonged culture hold further 
limitations for the usage of hESC. 
Due to all these limitations and risks, and despite all the hoped and hyped potential of hESC, 
there are no approved treatments which utilize ESC, yet. However, one step into this direction 
has been carried out in January 2009, when the world’s first hESC trial was approved by the 
FDA (United States Food and Drug Administration). This trial now investigates the 
transplantation of hESC-derived cell populations into spinal cord-injured humans. 
5.1.3 ADULT STEM CELLS 
Adult stem cells (also called somatic stem cells) are undifferentiated cells, found among 
differentiated cells in a tissue or organ after embryonic development. Under certain 
physiologic - or experimental conditions - the can renew themselves and can differentiate to 
yield some or all of the specialized cell types of the corresponding tissue. They are found in 
nearly all tissues and also throughout the whole lifetime of an organism. Their primary tasks 
in organisms are maintenance and repair of their tissue of origin. In some organs, such as gut 
or bone marrow, stem cells regularly divide to repair or replace worn out or damaged tissue. 
In other organs, like pancreas or heart, stem cells divide only under special conditions. 
The most common source of adult stem cells is the bone marrow, where at least three 
different types can be distinguished: haematopoietic – forming blood cells- , endothelial – 
forming the vascular systems- and mesenchymal stem cells –forming bone, cartilage, muscle, 
fat and fibroblasts. Furthermore stem cells are found in the pancreas [1], the liver [22], the gut 
[23], somatic muscles [24], the heart [25], the skin [26], in neuronal tissue (brain, olfactory 
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bulb, spinal cord) [27] and fat tissue [28]. Also findings of corneal [29], mammary [30], 
salivary [31], dental pulp [32] and thymic [33] stem or progenitor cells have been reported. 
Although adult stem cells are found throughout the body, there is only a very small number of 
stem cells in each tissue. And once removed from the body, their capacity to divide is no 
longer unlimited, making it essential to develop protocols for growing larger quantities in 
laboratory.  
Corresponding to their natural task most adult stem cells are multi- or oligopotent. Either 
regularly or due to a trigger -like a damaged tissue- they divide and differentiate into cell 
types from the tissue they reside in. However, more and more reports are showing that there 
are adult stem cells, which can cross the lineage-boundaries and differentiate into cell types 
from another tissue or even germ layer [34-36].  
Although the potential of adult stem cells seems to need a bit more help than that of ESC, 
there are numerous advantages they have over ESC. First of all, there is no ethical concern 
about their application. Adult stem cells are found throughout the whole human body and no 
life is harmed by their extraction. Furthermore, their cancerogenity is considered very low 
compared to ESC. They also offer the unique option of a treatment individually designed for 
each patient. Individual drug response could be monitored in vitro on target cells, which have 
been generated from the patients own stem cells. Also cells, tissues or organs which have 
been produced by autogenic stem cells, could be transplanted for replacing their damaged 
predecessor. Thereby, the risk of a transplant rejection is minimized.  
Therapies with adult stem cells have been used for more than 4 decades now. Since the late 
1960s bone marrow transplants are applicated for the successful treatment of leukaemia and 
other bone/blood related cancers.  
5.1.4 OTHER TYPES OF STEM CELLS 
So the main two types of stem cells have been described: embryonic and adult stem cells. 
However, there are at least two more sources of stem cells, which are known yet.  
Fetal stem cells are derived from the fetus itself or from extra-embryonic structures, which are 
also of fetal origin. This structures comprise umbilical cord blood, amniotic fluid, Wharton`s 
jelly, the amniotic membrane and the placenta. Classification of these cells is not finished yet. 
Based on proliferation rates and plasticity features they seem to be intermediates between 
embryonic and adult stem cells. And also transcriptomic and proteomic analysis indicate the 
same conclusion [37, 38].  
 5 PSC AND MSC - TWO SOURCES OF HUMAN ADULT STEM CELLS AND THEIR EPITHELIAL AND ENDOTHELIAL POTENTIAL  
15 
Another option for the production of stem cells is dedifferentiation. This is a natural 
phenomenon observed in plants, worms and amphibians, where mature somatic cells loose 
their properties to reach a state which is comparable to that of stem or progenitor cells. In 
mammalians, however, this phenomenon does not occur naturally. By genetically 
reprogramming adult somatic cells, though, it is possible to produce cells of an embryonic-
like type. These cells are called induced pluripotent stem cells (iPS). Mouse iPS were first 
reported in 2006 [39] and human iPSC one year later [40, 41] in late 2007. For producing iPS 
somatic cells (mostly fibroblasts) are transfected with typical ESC-associated genes. These 
genes comprise at least Oct-3/4 and Sox2, although transfection of additional factors can 
enhance the induction efficiency. iPS demonstrate important characteristics of ESC as 
expression of certain stem cell markers, a similar proliferation rate, embryoid body and also 
teratoma formation, pluripotency and plasticity. So far transfection has mostly been achieved 
by viral vectors and therefore cells produced in this way bear the increased potential risk of 
cancerogenity after implantation. However, in 2009 a protocol was established which renders 
viruses unnecessary as proteins are directly delivered by means of cell penetrating peptides 
[42]. 
5.1.5 APPLIED STEM CELLS 
5.1.5.1 PSC 
Pancreatic Stem Cells (PSC) are isolated from the exocrine acinary parts of the human 
pancreas. They were described for the first time in 2004 [1] and raised attention due to their 
spontaneous pluripotency in vitro, which is scarcely found in adult stem cells.  
A detailed description of these cells are found in Chapter  5.3.1 and  5.3.3. 
5.1.5.2 MSC 
Mesenchymal stem cells (MSC) are one of the three groups of adult stem cells, which are 
found in bone marrow ( 5.1.3) [43]. Alternatively, they can be isolated from peripheral blood 
[44], from lung [45], heart [46] or adipose tissue [47]. MSC have a very high capacity for 
self-renewal, while remaining in an undifferentiated state. Minimal criteria for the 
identification of MSC are the positive expression of CD 44, CD 73, CD 90 and CD 105 and 
negative expression of CD 45, CD 34, CD 14 or CD 11b, CD 79a or CD 19 and HLA-DR 
antigens [48]. Under standard culture conditions they adhere to the surface and they show 
multipotency by differentiating in vitro into adipocytes, chondrocytes and osteoblasts [49]. In 
vivo they are even able to generate endodermal cells like hepatic, intestinal, pancreatic and 
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lung epithelium [50, 51]. More recent studies suggest even an in vitro multi-lineage 
differentiation and therefore pluripotency of MSC [52]. 
Apart from their potency MSC are of great interest in research as they exhibit profound 
immunomodulative abilities in vitro and in vivo [53]. Firstly, immunosupression is shown by 
reducing functions of T-, B- and NK-cells comprising proliferation, production of cytokines 
and cellular cytotoxicity [54]. One apparent effect is the amelioration of acute graft-versus-
host disease after administration of MSC [55]. Secondly, MSC have the so called 
immunoprivilege. This means that autologous and allogeneic MSC are protected from 
immunological defence mechanisms and are not rejected by the immune system [56]. 
Furthermore, their conditioned medium has shown to reduce stress induced by cigarette 
smoke [57] and to inhibit proliferation of lung cancer cell lines [58].  
By far, MSC are the adult stem cells most widely used in research all over the world. Several 
experimental studies have already shown the potential of MSC in the regeneration of infarcted 
heart muscle by injection of these cells near the infarcted site, and in the treatment of 
musculo-skeletal disorders, repairing large bone and cartilage defects [59]. Other clinical 
applications currently being investigated are osteogenesis imperfecta, Alzheimer’s disease, 
spinal cord injury, HIV, liver cirrhosis, aplastic anemia and ALS [60-63].  
5.1.6  AIMS AND EXPERIMENTAL OVERVIEW 
Directed differentiation is the crucial point when large numbers of differentiated cells are to 
be generated from stem cells. This is necessary e.g. for usage in in vitro screening of 
pharmaceutical substances or for transplantation in humans. This study was designed to 
investigate the potential of the human adult stem cells PSC and MSC to give rise to epithelial- 
and endothelial-like cells.  
MSC are known since the 1960s and have been thoroughly characterized (even though not all 
encompassing) since then. On the contrary PSC were only just discovered to the beginning of 
this thesis. A systematic characterization regarding their immanent endothelial, epithelial and 
stem cell properties was therefore one major aim of this thesis. Also the influence of different 
extracellular matrices (ECM) on expression of the analyzed markers was of interest. 
Furthermore, the influence of air-interface culture and a method to produce spheroids by 
means of centrifugation were investigated. 
Focus of differentiation approaches were endothelial and epithelial lineages. Especially the 
lung is target of many drug therapies. Not only topical drugs for asthma, bronchitis, COPD 
(chronic obstructive pulmonary disease) and other lung diseases are applied but also 
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inhalational anaesthetics and nicotine for smoking cessation. Individually adapted screening 
of pharmaceutical agents by means of differentiated autologous stem cells could therefore be 
good for optimizing drug response rate. Stem cell generated endothelial cells may serve the 
same purpose for e.g. blood pressure and anti-inflammatory relevant drugs. Furthermore, they 
may vascularise engineered tissue before and/or after transplantation as primary endothelial 
cells already did [64]. Detailed information to endothelial end epithelial cell types can be 
found in Chapter  5.4 and  5.5, respectively.  
For endothelial differentiation growth factors VEGF and bFGF were applied as well as 
starving of stem cells to increase responsiveness to these factors  5.4). To achieve epithelial 
differentiation of PSC and MSC conditioned medium of the lung epithelial cells A549 and 
Calu-3 were used and additionally stem cells were cultured upon these fixed epithelial cells 
(see Chapter  5.5).  
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5.2 MATERIAL AND METHODS 
5.2.1 ROUTINE CELL CULTURE AND BASIC CELL CULTURE DURING EXPERIMENTS 
For characterizing and furthermore investigating cells of any kind, the cells need to be 
subjected to a routine cell culture. This culture has to stick to a strict protocol, for ensuring the 
data received being due to the experimental set-up and not to changes in the routine cell 
culture. Naturally, the protocols differ from cell type to cell type to meet the particular needs 
of each cell.  
Cells applied in this study were the stem cells PSC (pancreatic stem cells) and MSC 
(mesenchymal stem cells), the lung epithelial stem cells A549 and Calu-3, the primary lung 
epithelial cells hAEpC, the endothelial cells HUVEC (human umbilical vein endothelial cells) 
and also the colon-derived Caco-2. 
The adult human stem cells PSC were a generous gift from Fraunhofer Institut St. Ingbert, 
Germany. Cell isolation was described by Kruse et al. in 2004 [1]. All experiments were 
performed with cells from passages 13 to 23 from the clone Cepan 3b. PSC were maintained 
in a primary medium (PM) consisting of Dulbecco's modified Eagle's medium - High Glucose 
with L-Glutamin (DMEM, GIBCO Invitrogen; Karlsruhe, Germany) supplemented with 10 % 
fetal bovine serum gold (FBS GOLD), 100 units/ml penicillin and 100 µg/ml streptomycin 
(all from PAA; Pasching, Austria). PSC were seeded at a density of 5 x 105 in T-75 cell 
culture flasks and routinely subcultured at 80 to 90 % confluence. 
Also the human MSC were a gift from Fraunhofer Institut St. Ingbert, Germany, which 
isolated the cells from the bone marrow of a 60 year old male Caucasian donor according to a 
protocol described in 2002 [65]. Before passing the cells on, MSC were routinely tested for 
positive expression of CD 29, CD 44, CD 73, CD 105 and CD 166 and for chondrogeneic and 
osteogeneic differentiation. All experiments were performed with cells from passages 7 to 15. 
MSC were maintained in alpha-minimum essential medium with stabile L-Glutamin  and 
without ribonucleosides and deoxynucleosides (alpha-MEM; Pan-Biotech, Aidenbach, 
Germany) supplemented with 15% fetal bovine serum (FBS, also Pan-Biotech) and 100 
units/ml penicillin and 100 µg/ml streptomycin (PAA). MSC were seeded at a density of 5 x 
105 in T-75 cell culture flasks and routinely subcultured at 80 to 90 % confluence. 
A549 (ATCC-No: CCL-185) were maintained in RPMI-1640 - High Glucose with L-
Glutamin (RPMI, GIBCO) supplemented with 10 % FBS (PAA). Subculture ratio was 1:50. 
Calu-3 (ATCC-No: HTB-55) were maintained in RPMI-1640 - High Glucose with L-
Glutamin and without phenolred (PAA) supplemented with 10 % FBS GOLD and 1 mM 
 5 PSC AND MSC - TWO SOURCES OF HUMAN ADULT STEM CELLS AND THEIR EPITHELIAL AND ENDOTHELIAL POTENTIAL  
19 
sodium pyruvate (Lonzy, Basel, Switzerland). They were subcultured in a ratio of either 1:5 
or 1:10. 
HUVEC (Promocell, Heidelberg, Germany) were maintained in Endothelial Growth Medium 
II (ECGM, Promocell) and subcultured in a ratio of 1:5 once to twice a week (in contrast to 
all other cells).  
Caco-2 were maintained in RPMI-1640 – High Glucose with L-Glutamin (RPMI, GIBCO) 
and supplemented with 10 % FBS (PAA). They were subcultured in a ratio of 1:10. 
hAEpC were isolated and cultured as described by Daum [66]. 
All cells were routinely incubated at 37°C in 5 % CO2 and regularly tested for mycoplasm 
infections. Subculturing was performed once (HUVEC once to twice) and medium was 
changed three times a week.  
During all experiments the medium was replaced also three times a week. For MSC the 
underlying medium during experiments was the same as described for routine culture. For 
PSC the experimental medium was a particularly composed differentiation medium (DM). 
This medium consisted of DMEM supplemented with 20 % FBS GOLD, 2 mM L-Glutamine 
(Cambrex; Verviers, Belgium), 100 units/ml penicillin, 100 µg/ml streptomycin, 10 µl/ml 
amino acids non essential (all from PAA) and 0.0007 % β-mercapto ethanol (Sigma, 
Schnelldorf, Germany). Standard substrate was normal tissue culture plastic (TCP). This 
information is true as long as not otherwise stated. 
5.2.2 CULTURE ON VARIOUS EXTRACELLULAR MATRICES 
The development of stem cells is not only influenced by soluble molecules in the medium but 
also by the substrates they are grown on. This has been shown for various extracellular 
matrices (ECM) in the past [67, 68].  
Therefore, PSC were exposed to the influence of five different matrices: collagen I (C I), 
collagen IV (C IV), fibronectin (FN), laminin (LN) and poly-D-lysine (PDL) (all Biocoat 
Cellware, BDBiosciences, Heidelberg, Germany). PSC were seeded in a density of 
25,000 cells/cm2 and were left to grow for 21 days in PM, before they were harvested for 
further investigations. TCP served as control. All experiments were performed twice (n=2). 
5.2.3 GENERATION AND ANALYSIS OF ORGANOID BODIES 
Three methods are known in literature for generating spheroids, in which spontaneous stem 
cell differentiation can occur: centrifugation of cell suspension [69-71], hanging drop culture 
[1, 72] and continuous spinning or shaking of a cell suspension [73, 74] (Figure 6). 
For PSC the hanging drop method is already established [1]. In order to receive bigger 
spheroids a centrifugation protocol was established. A suspension of 250,000 PSC in 5 ml 
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was centrifuged for 5 min at 500 g in a 15 ml Falcon tube (BD). Afterwards the supernatant 
was replaced by fresh medium. Overnight the cell pellet rounded up and was detached from 
the surface by gently tilting the tube. Medium was replaced every 2 days and spheroids were 
left to grow until day 23. Samples were histologically investigated every couple of days. 
5.2.4 AIR INTERFACE CULTURE  
Unilateral access to medium can influence the development of a certain cell type [75]. To 
achieve such environment, PSC were exposed to an Air Interface Culture (AIF). 
For creating this AIF culture 12-well Transwell®s with permeable filter inserts (type 3460, 
pore size 0.4 µm, 1.13 cm2, Corning, Wiesbaden, Germany) were applied (Figure 2a). These 
devices allow a separation of a lower and upper compartment by a water - and electrolyte -
 permeable membrane (Figure 2b). PSC were seeded in a density of 50,000 cells per well in 
the upper compartment. The upper compartment was filled with a total volume of 0.5 ml and 
the lower with 1.5 ml of medium, resulting in a balanced hydrostatic pressure on both sides of 
the membrane. At day 2 medium of the upper compartment was removed. Volume of medium 
of the lower compartment was then reduced to 1.2 ml. This was necessary, since medium 
otherwise would have infiltrated upper compartment through the microporous membrane and 
could thereby influence adherence of cells on membrane. At day 7 first part of cells were 
subdued to histological preparation. Remaining cells were allowed to grow until day 21.  
 
Transwell insert
upper compartment
Membrane
lower compartmenta) b)
 
Figure 2: Picture (a) and schematic drawing (b) of a 12 well Transwell®. 
 
5.2.5 HISTOLOGICAL PREPARATION OF ORGANOID BODIES AND AIF CULTURE 
Histological preparation was performed as follows: OBs or cells adhering to filter membrane 
of Transwell®, respectively, were fixed in a 4 % formaldehyde solution at RT for 30 min. 
Samples were then incubated at RT subsequently with ethanol 70 %, 96 % and 100 % for 
dehydration and stored temporarily in xylene. For mounting samples were covered with 
paraffin wax overnight at 60°C and embedded next morning. Samples were cut with a 
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microtome (Leica Microsystems, Nussloch, Germany) in 4 µm thick sections and 
subsequently dewaxed with xylene. Rehydration was performed by subsequent incubation for 
10 min at a time with ethanol 100 %, 96 % and 70 % at RT and following rinsing with 
deionised water. Slices were stained with 3 % solution of Alcian Blu (Sigma-Aldrich) for 
30 min at RT, rinsed with deionised water and counterstained with fast nuclear red 29 (Sigma-
Aldrich) for 5 min at RT. Samples were then again dehydrated by the above mentioned 
ethanol series and stored in xylene. Sections were mounted with coverslips by using Roti-
Histokitt (Roth, Karlsruhe, Germany) and subsequently examined with an Axiovert XY light 
microscope (Carl Zeiss, Jena, Germany) at 400x magnification. 
5.2.6 PROTOCOLS FOR ENDOTHELIAL DIFFERENTIATION 
Literature holds different protocols for endothelial differentiation of stem cells ready. These 
protocols employ mostly the growth factors VEGF (vascular endothelial growth factor) and 
bFGF (basic fibroblastic growth factor) in various concentrations and orders. Also special 
media are hold for sale, which are designed for forcing endothelial differentiation, i.e. 
endothelial growth medium 2 (ECGM; PromoCell, Heidelberg, Germany). Furthermore, 
culture on FN is reported to enhance endothelial differentiation [76]. Also “starving” of stem 
cells, by culturing them for a short time in medium containing only little amounts of FBS, is 
known, to make these cells prone for subsequently added growth factors. 
This study applied three basic setups for inducing endothelial differentiation in PSC and MSC 
(for a schematic overview see Figure 14 in Chapter  5.4.1.2). 
For the first approach PSC were seeded at a density of 6,000 and MSC at 3,000 cells/cm2 in 
their respective routine culture medium. After three days the medium was replaced with the 
experimental medium containing VEGF (Chemicon, Hofheim, Germany) in concentrations of 
(I) 10, (II) 20 and (III) 50 ng/ml, while plain medium served as control. Cells were analyzed 
after 3, 7 and 14 days (n=2). 
For the second setup PSC were seeded at a density of 15,000 and MSC at 7,500 cells/cm2 
either on normal TCP or on FN-coated dishes. The medium consisted either of (I) pure 
experimental medium or of (II) medium supplemented with 20 ng/ml bFGF (Invitrogen, 
Karlsruhe, Germany) and 50 ng/ml VEGF or of (III) medium supplemented during the first 
7 days with bFGF and for the subsequent 14 days with VEGF. Furthermore, stem cells were 
cultured in (IV) ECGM 2. The growth factor cocktail in this medium contains 1 µg/ml 
Ascorbic Acid, 10 ng/ml bFGF, 5 ng/ml epidermal Growth Factor, 22.5 µg/ml Heparin, 
0.2 µg/ml Hydrocortisone, 20 ng/ml Insulin-like Growth Factor and VEGF 0.5 µg/ml. All 
cells were analyzed after 21 days (n=2). 
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For the third approach PSC were seeded at a half-confluent density of 15,000 and MSC at 
7,500 cells/cm2 in experimental medium containing 0.1 % FBS only. After 48 h the medium 
was replaced by some which contained 20 % FBS instead. This medium was either pure or 
supplemented with (I) 50 ng/ml VEGF or with (II) 50 ng/ml VEGF and 20 ng/ml bFGF. Cells 
were analyzed after 12 days of cultivation (n=2). 
5.2.7 IN VITRO ANGIOGENESIS 
Beside determination of mRNA (Chapter  5.2.9) and protein expression ( 5.2.11,   5.2.12 and 
 5.2.13) differentiation of stem cells can be determined by their ”behavior”. For instance, the 
formation of capillaries in a semisolid medium is considered as a proof for endothelial 
potential [77].  
Therefore, the ability of stem cells to develop such tubes was investigated by applying an in 
vitro angiogenesis assay kit (Chemicon) according to the manufacturer’s instruction. 
Summarily, a volume of 50 µl of ECMatrixTM solution was filled into one well of a 96-well 
plate and incubated overnight at 37°C. Prior, PSC and MSC had been incubated with medium 
containing 50 ng/ml VEGF or with 50 ng/ml VEGF and 20 ng/ml bFGF for 7 days. After 
trypsinization 10,000 cells were suspended in 50 µl of the corresponding medium onto the 
solidified ECMatrixTM. Stem cells in their routine culture medium (PSC in PM and MSC in 
MEM) served as controls. Also Caco-2 were applied as a negative control. Cells were 
incubated on the matrix for up to 8 h, while they were microscopically investigated every two 
hours (n=3).  
5.2.8 PROTOCOLS FOR EPITHELIAL DIFFERENTIATION 
Unlike endothelial differentiation there are nearly no established protocols for differentiating 
stem cells into epithelial-like cells found in literature. Therefore, other promising approaches 
were applied, which involved the presence of epithelial cells during the differentiation process 
of stem cells. A549 and Calu-3 were the cells of choice. Stem cells were either incubated with 
conditioned medium of these cells, cultured on fixed cells or exposed to both stimuli (for 
schematic overview see Figure 20 in Chapter  5.5.1.2). 
As described earlier ( 5.2.1) during routine cell culture medium of all cells was changed three 
times, also that of A549 and Calu-3. For receiving conditioned medium, this used medium 
was not discarded but sterile-filtered and diluted in a ratio of 1:2 with the experimental stem 
cell medium. Medium consisting of 50% unused epithelial medium and 50% experimental 
stem cell medium served as control and was named unconditioned medium. Stem cells were 
then cultured for 21 days with the respective medium (n=4).  
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For the second approach epithelial cells were seeded in 6-well plates and allowed to grow 
(A549 at 20,000 cells/cm2 for 2 days and Calu-3 at 40,000 cells/cm2 for 4 days). Subsequently, 
they were washed with sterile PBS (phosphate buffered saline: 129 mM NaCl, 2.5 mM KCl, 
7.4 mM Na2HPO4 x 7 H2O, 1.3 mM KH2PO4) and fixed with 70 % isopropanol for 10 min at 
RT. Finally, fixed cells were washed twice with sterile PBS before stem cells were seeded on 
top (PSC at a density of 15,000 and MSC at 10,000 cells/cm2). Stem cells were cultured for 
12 days either with unconditioned medium before being analyzed. 
For the third approach direct and indirect coculture were combined. 
5.2.9 REVERSE TRANSCRIPTASE- POLYMER CHAIN REACTION (RT-PCR) 
For analyzing the gene expression state of control (A549; Calu-3, HUVEC) and stem cells 
(PSC, MSC) RT-PCR was applied. 
Table 1: Specific primers used for RT-PCR (end: endothelial; ep: epithelial; sc: stem cell). 
 
Primer name RefSeq Ids Primer sequences Amplicon 
size [bp] 
Character 
 
CD°34 
CD 45 
 
NM_001773 
NM_002838 
 
F: 5'-gcaagccaccagagctattc-3' 
F: 5'-gtacagacgcctcaccttcc-3' 
 
R:5'-aagcagggctgtgagacact-3' 
R: 5'-ctgtgatggtggtgttggag-3' 
 
292 
262 
 
end/sc 
sc 
CD 71 NM_003234 F: 5'-gaactacaccgaccctcgtg-3' R: 5'-caggctgaaccgggtatatg-3' 293 sc 
CDH 1 (CD 324) NM_004360 F: 5'-gctggagattaatccggaca-3' R: 5'-acccacctctaaggccatct-3' 388 ep/sc 
CDH 5 (CD 144) NM_001795 F: 5'-ctgcacatctacggctacga-3' R: 5'-tggagtttgctatcccaagg-3' 335 end 
c-kit (CD 117) NM_000222 F: 5'-cttgcatccaactccaggat-3' R: 5'-gcagaattggagaagccttg-3' 234 sc 
CTNβ1 NM_001904 F: 5'-tgcagttcgccttcactatg-3' R: 5'-ctgcacaaacaatggaatgg-3' 355 ep 
endoglin (CD 105) NM_000118 F: 5'-cactagccaggtctcgaagg-3' R: 5'-gtcattcagctcagcagcag-3' 358 end/sc 
EpCAM (CD 326) NM_002354 F: 5'-cgtcaatgccagtgtacttca-3' R: 5'-gttcttctgaccccagcagt-3' 251 ep 
GAPDH NM_002046 F: 5'-gtcagtggtggacctgacct-3' R: 5'-tgctgtagccaaattcgttg-3' 245  
K 7 NM_005556 F: 5'- caggaactcatgagcgtgaa-3' R: 5'-gggtgggaatcttcttgtga-3' 346 ep 
K 8 NM_002273 F: 5'- ccgacgagatcaacttcctc-3' R: 5'-ggctctgcagctcctcatac-3' 222 ep 
K 18 NM_199187 F: 5'- aaggcctacaagcccagatt-3' R: 5'-gagctgctccatctgtaggg-3' 350 ep 
K 19 NM_002276 F: 5'- tttgagacggaacaggctct-3' R: 5'-aatccacctccacactgacc-3' 211 ep 
PECAM 1 (CD 31) NM_000442 F: 5'-gggagaagtgaccagagcaa-3' R: 5'-tgagaggtggtgctgacatc-3' 331 end/sc 
VCAM 1 (CD 106) NM_001078 F: 5'-attgacttgcagcaccacag-3' R: 5'-atctccagcctgtcaaatgg-3' 318 end 
VEGFR 1 (FLT-1) NM_002019 F: 5'-ttgattgaggagctgcactg-3' R: 5'-ctgggccctcaaatgtagaa-3' 321 end 
VEGFR 2 (CD 309, KDR) NM_002253 F: 5'-tgaagatgggaaggatttgc-3' R: 5'-agccagagctgcatcatttt-3' 361 end 
vWF NM_000552 F: 5'-tccgaggctgagtttgaagt-3' R: 5'-cgggatcacaatgaccttct-3' 375 end 
ZO-1 NM_003257 F: 5'-aaagggaaagcctcctgaag-3' R: 5'-cggtttggtggtctgaaagt-3' 270 ep 
ZO-1-iso NM_175610 
NM_003257 
F: 5'-catagaatagactcccctgg-3' R: 5'-gcttgaggactcgtatctgt-3' 234 
474 
ep 
ep 
 
mRNA was isolated by use of RNeasy Mini Kit and cDNA was synthesized using Omniscript 
RT Kit. Specific PCR was carried out with Taq PCR Master Mix Kit (all by Qiagen, Hilden, 
Germany) in a final volume of 50 µl with 25 pmol of each nucleotide primer (see Table ) and 
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with a total of 35 cycles. Temperatures applied during amplification were 95°C for 
denaturation, 52°C for annealing and 72°C for extension. Amplification of GAPDH served as 
internal control for sample loading. All amplifications were carried out in PTC-200 Peltier 
Thermal Cycler (MJ Research, GMI, Minnesota, USA) (Figure 3). 1 g of agarose Serva for 
PCR (Serva, Heidelberg, Germany) was suspended in 100 ml of TAE buffer (40 mMTris 
base, 20 mM acetic acid, 1 mM EDTA) and microwaved until agarose was completely 
dissolved. Ethidium bromide was added to a final concentration of 0.5 µm/ml and solution 
was poured into a gel tray with well comb. After solidification agarose gel was transferred to 
electrophoresis unit (Mini-sub Cell GT, BioRAD), where it was covered with TBE buffer 
(45 mM Tris-borate, 1 mM EDTA). All samples were topped off with loading buffer (Serva) 
and loaded into wells of the gel. First and last lane were loaded with molecular weight marker 
(either peqGOLD DNA Leiter-Mix 10 000 – 100 bp or peqGOLD 50bp DNA-Leiter 1 000 – 
50 bp; PEQLAB Biotechnologie GmbH, Erlangen, Germany). Gels were run for 30 min at 
100 mV and subsequently analyzed in UV light (GelDOC, BioRad)., 
 
 
 
Figure 3:  PCR thermal cycler by MJ Research. 
 
5.2.10 DENSITOMETRIC ANALYSIS OF RT-PCR DATA 
For a semi-quantitative analysis PCR gels were examined by creating a density plot profile in 
ImageJ (National Institute of Health, USA). All data were corrected for background by 
substracting values for an empty lane of the same gel. Densitometric intensity was defined by 
integration of the area under the peak corresponding to a band. The graph was designed by 
means of SigmaPlot 10 (Systat Software, Inc., Germany). 
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5.2.11 IMMUNOCYTOCHEMISTRY 
Beside the analysis of the gene expression state by RT-PCR also the investigation of specific 
protein expression is pivotal when examining the developmental state of stem cells. In this 
thesis three methods were applied for visualizing the actual gene expression: 
immunocytochemistry, fluorescence activated cell sorting ( 5.2.12) and Westernblot ( 5.2.13). 
For immunocytochemistry cells were incubated in routine cell culture medium on glass slides 
for 7 days. Cells were washed three times in PBS before they were fixed in 80 % methanol for 
5 min at 4°C. Subsequently, they were incubated with primary monoclonal antibodies, these 
being mouse antibodies against CDH 1 (cadherin 1, Chemicon), endoglin (BD Biosciences, 
Heidelberg, Germany), VCAM 1 (Dianova, Hamburg, Germany), VEGFR 1 (R&D Systems, 
Wiesbaden, Germany), vWF (BD Biosciences) and the guinea pig antibody against 
panKeratin (Progen, Heidelberg, Germany) diluted in PBS / 1 % BSA overnight at 4°C. 
Subsequently, cells were again rinsed three times with PBS. Mouse antibodies endoglin, 
VCAM 1, VEGFR 1 and vWF were then incubated with the secondary goat anti-mouse 
antibody (FITC-conjugated; Dianova). At the same time the guinea pig antibody was 
incubated with Cy2-conjugated donkey anti-guinea pig (Dianova). Both secondary antibody 
solutions were supplemented with propidium iodide (500 µg/ml; Sigma, Schnelldorf, 
Germany) for nuclear counterstaining and cells were left at RT for 30 min in the dark. Agaian, 
glass slides were rinsed three times with PBS, mounted with Fluosave (CalBiochem, 
Gibbstown, NJ, USA) and masked with a coverslip. 
Fluorescence imaging was performed using a BioRAD MRC-1024 confocal laser scanning 
microscope equipped with an argon-krypton laser The objective used was an oil immersion 
objective 40x NA-1.3. 
5.2.12 FLUORESCENCE ACTIVATED CELL SORTING (FACS) 
While immunocytochemistry primarily enables a qualitative and visual analysis of present 
proteins, FACS is a method, which allows for exact quantitative measurements. Hence, it was 
applied for characterizing of immanent characteristics of PSC.  
After trypsinating 107 PSC were suspended in 1 ml buffer (PBS containing 2 %FBS) and 
incubated with the same antibodies described in  5.2.11 against endoglin, VCAM 1, VEGFR 1 
and panKeratin. After 30 min in ice cells were washed twice with buffer and then incubated 
with secondary Cy-2 (for panKeratin) or FITC conjugated (for all other proteins) antibodies. 
After again 30 min on ice in the dark cells were washed in buffer and resuspended in 500 µl 
FACSFlow Sheath Fluid (Becton Dickinson, Erembodegem, Belgium). PSC were analyzed in 
channel FL 1 of a FACSCalibur (Figure 4) and by the use of CellQuest Pro software (both 
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Becton Dickinson). Samples which have been treated with secondary antibody only served as 
control for detecting unspecific antibody binding. 
 
 
Figure 4: FacsCalibur® by Becton Dickinson. 
 
5.2.13 WESTERNBLOT 
Westernblot is a very established method for a visual and semi quantitative analysis of protein 
expression. It was applied to supplement immunocytochemistry and FACS. At first, proteins 
are separated by size by means of SDS- polyacrylamide gel electrophoresis (SDS-PAGE). 
Then the proteins are transferred by electric transfer, the so called blotting, to a nitrocellulose 
membrane. This membrane is subsequently treated with first and secondary antibody and 
eventually with a dye to visualize the corresponding proteins. 
(Whole sample handling for Westernblot was performed on ice to inactivate proteases) 
Sample preparation: for retrieving samples, adherent cells were rinsed twice with ice-cold 
PBS. PBS was then added and cells removed by means of a cell scraper. Cell suspension was 
centrifuged for 10 min at 4°C at 3000 rpm. Supernatant was discarded, pellet resuspended in 
PBS and again centrifuged. Supernatant was again discarded and pellet was stored at -80°C.  
Protein was extracted by dissolving frozen pellet in RIPA-buffer (Radio-Immunoprecipitation 
Assay; 1 ml: 10 µl 1 M Tris pH 7.2, 300 µl 0.5 M NaCl, 100 µl 10 % SDS, 10 µl 10 % 
sodium deoxycholate, 50 µl 100mM EDTA, 520 µl H2O, 1 µl 1 µg/µl aprotinin, 1 µl 1 µg/µl 
leupeptin, 1 µl 1 µg/µl pepstatin, 5 µl 100 mM vanadate, 5 µl 10 mM PEFA-bloc). Solution 
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was homogenized, centrifuged and supernatant was subjected to protein quantification by 
means of BCA-Kit (Bichinchonic Acid Kit; Sigma). Samples were incubated with a mixture 
of solutions A and B of the kit for 30 min at 37°C before absorbance at 550 nm (Infinite 200 
M multimode microplate reader; Tecan, Crailsheim, Germany). 
was determined. Calibration was performed with a curve of BSA-protein solutions. 
Sample volumes corresponding to 30 µg protein were mixed with the same volume of double 
concentrated reducing buffer (“Lämmli”-buffer: 0.12 M pH 6.8 Tris-HCl, 8 % SDS, 20 % 
glycerine, 10 % β-mercapto ethanol, 0.1 % bromphenolblue). Samples were heated for 5 min 
at 95°C and and then topped up to 30 µl with normal concentrated reducing buffer.   
Electrophoresis: electrophoresis chamber (Mini Protean II, BioRad, Munich, Germany) was 
filled with a 10 % separation gel (10 ml contain 0.75 ml glycerol (50 % V/V), 3.42 ml water, 
2.5 ml lower-buffer (1.5 M Tris-HCl pH 8.8, 0.4 % SDS (sodium dodecyl sulfate)), 3,33 ml 
acrylamide (T40 %-C3.7%), 50 µl APS (ammonium persulfate 10 % W/V) and 5 µl TEMED 
(tetramethylethylenediamine) and subsequently with a 2.8 % collection gel (3.85 ml contain 
2.6 ml water, 0.95 l upper-buffer (0.5 M Tris-HCl pH 6.8, 0.4% SDS), 0.3 ml acrylamide 
(T40 %-C3.7%), 22.5 µl APS (10 % W/V) and 5 µl TEMED) in which a comb was inserted 
for retrieving sample wells. After solidification of the gels samples were loaded in wells and 
the chamber was filled with running buffer (0,025 M Tris, 0.192 glycine, 0.1 % SDS) and 
electrophoresis was started. Voltage was gradually increased up to 100 V and gel was run for 
up to 2.5 h.  
Blotting: Proteins were transferred from gel to membrane (0.45 µm reinforced nitrocellulose 
BA-S 85; Schleicher & Schuell, Bath, UK) in a blotting chamber (Mini Trans-Blot 
Electrophoretic Transfer Cell; BioRad)) between layers of Whatman 3MM Chr paper (Sigma-
Aldrich) and wash cloths. Blot was run in blotting buffer (0.0.25 M Tris-HCl pH 8.3, 0.192 M 
glycine, 20 % methanol) and with ice pack for 2 h at 48 V. 
Visualisation: For protein staining membrane was incubated for 5 min in Ponceau S staining 
solution (Sigma) at RT and then decolorized with 5 % acidic acid. Membrane with remaining 
stained protein bands was scanned and subsequently totally decolorized with blocking buffer 
(0.02 M Tris-HCl, 0.15 mM NaCl, 5% skimmed milk powder; pH 7.5). For antibody staining 
the blocking buffer was discarded and primary antibody was added in 12 ml fresh blocking 
buffer and incubated for 90 min at RT while gently rocking. Primary antibodies used were 
against EpCAM (C-10) and AQP-5 (H-200) (both Santa Cruz Biotechnology, Dallas, USA) 
and against CDH 1 and GAPDH (all Chemicon). Membrane was then rinsed twice for 5 min 
with a solution of PBS and 5 % Triton X and subsequently for 2 min with PBS only. Then 
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procedure was repeated in the same manner for the secondary antibodys. Membrane was then 
incubated in a mixture of 200 µl BCIP/NBT stock solution (nitro-blue tetrazolium chloride / 
5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt; Sigma-Aldrich) and 10 ml buffer 
(0.1 M Tris-HCl, 0.1 M NaCl, 0.05 M MgCl2; pH 9.5).When protein bands became 
sufficiently visible, staining was stopped with water. Membrane was dried between 3MM Chr 
paper, wrapped in polythene film and finally scanned.  
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5.3 CHARACTERIZATION OF PSC 
5.3.1 INTRODUCTION 
PSC are a type of adult stem cells, which are relatively new. During course of this thesis only 
five publications dealt with this new stem cell type of either human [1, 78] or rat [1, 79, 80] 
origin. For the first time they were described by Kruse in 2004 [1], where he explicates their 
isolation, the generation of organoid bodies (OBs) and the spontaneous differentiation within 
these OBs. Due to their morphologic and immunohistochemical similarity to pancreatic 
stellate cells, which are located within the interlobular septa and interacinar areas of the 
pancreas, he termed them PSLC - Pancreatic Stellate Like Cells. It was not before 2007 that 
they were renamed PSC – Pancreatic Stem Cells [80]. 
Source of human PSC are pancreatic acini obtained from patients with diseases of the 
pancreas. The isolation yields cells of a spindle-like or stellate shape, resembling 
undifferentiated fibroblasts. The obtained human PSC can be grown in their undifferentiated 
state for at least 20 passages. For inducing spontaneous differentiation a protocol is used 
established for ESC. 600 cells are cultured in hanging drops below the lid of a Petri dish. 
After two days cells form aggregates. While these aggregates are named Embryonic Bodies, 
when originating from ESC, they are termed OBs for PSC. OBs are maintained in suspension 
culture for six days before they are plated on a gelatin matrix, where they are maintained for a 
minimum of seven weeks. During this period spontaneous differentiation into cell types from 
all three germ layers takes place: keratinocytes, nerve and glial cells from ectoderm; 
chondrocytes and muscle cells from mesoderm; exocrine and endocrine cells of the pancreas 
from endoderm. As they overcome lineage restrictions during differentiation, PSC are 
regarded as pluripotent adult stem cells. Establishment of these protocols and observation of 
spontaneous differentiation by Kruse [1] form the basis for all subsequent studies with PSC.  
Guldner was the first to try a directed differentiation of human PSC [78]. Co-culture of PSC 
with human myocardial biopsies led to a significant higher level of cardiomoycte 
characteristics as after spontaneous differentiation. Criterions were expression of muscle 
specific protein MF-20 and cardiac muscle protein troponin I and also occurrence of 
autonomously contracting cell clusters.  
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Table 1: Stem cell and other marker expression of rat PSC determined by Kruse [79] and Danner [80]. 
 
marker source / meaning mRNA protein ref. 
  primary clone primary  clone  
alk.phosphatase stem cell   pos  [79] 
amylase pancr. enzyme  pos  pos [79] 
Brachyury stem cell  pos   [79] 
CD 9 stem cell pos pos   [79, 80] 
CD 44 stem cell     [79] 
DMC1 meiosis pos neg (neg)  [80] 
GDF-9 oozyte / ovary pos/neg pos   [80] 
glucagon pancr. enzyme  pos   [79] 
nestin stem cell pos pos  pos [79, 80] 
neuro filaments neuron  pos  pos [79] 
Oct-4 stem cell pos pos pos  [79, 80] 
Pax 6 stem cell     [79] 
SCP3 meiosis pos/neg weak weak  [80] 
SSEA-1 stem cell pos pos pos pos [79, 80] 
Vasa germ cell pos pos   [80] 
α-Fetoprotein stem cell     [79] 
α-SMA mesenchym pos  pos pos [79] 
 
 
In 2006 two studies were published addressing differentiation behaviour of PSC originating 
from rats [79, 80]. Long-term culture of OBs (partially longer than one year) led to complex 
three-dimensional tissue-like structures with sizes up to 2 cm, termed tissue bodies [79]. 
While the surface was covered with a multi-layer epithelium the inner mass revealed canal-
like structures and an arrangement of cellular and organoid components, both features 
reminding of different stages of teratoma development. Tissue bodies generated permanently 
new cells of remarkable size at their surface, which were released into the medium [80]. 
Closer investigation of these cells revealed an oocytes-like morphology. Also the gene 
expression pattern showed distinct differences to “normal” PSC and similarities to oocytes. 
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These cells were therefore named Oocyte-Like Cells. Both studies were the first to deal not 
only with spontaneous differentiation properties of PSC but also with characterization of 
undifferentiated PSC. However, these cells were not of human but of rat originating from rat 
and, moreover, mainly markers typical for stem cells were investigated (Table 1). Further 
characterization of human PSC was still missing. 
Later publications dealt with directed differentiation in certain lineages and also partially with 
more detailed characterization of human PSC. These studies will be enlarged in the discussion 
( 5.3.3.) of this chapter. Immanent endothelial and epithelial properties in undifferentiated 
PSC, however, have not been investigated before. As differentiation into these lineages was to 
be examined in this thesis, a thorough investigation of the immanent characteristics 
concerning these lineages was pivotal. Otherwise success of differentiation protocol is not 
discernible.  
Also the influence of different substrates on stem cells is regarded as characteristic for the cell 
type. Certain matrices have therefore been investigated.  
Well known is the fact, that epithelial cell, i.e. Calu-3, express a different phenotype and 
morphology when cultured in AIF culture (Figure 5) compared to a conventional or submerse 
culture. In an AIF culture cells are grown on a semi-permeable filter membrane. The growth 
medium levels with this membrane, so that the upper or apical side of the cells is faced by air 
rather than medium. Also cells originating from either ESC or progenitor cells showed such 
different behaviour when cultured at AIF [81, 82]. Therefore, PSC were subjected to AIF 
culture to monitor morphological changes by light-microscopy.  
 
air
filter membrane
medium
conventional culture AIF culture
 
Figure 5: Schematic view of conventional and AIF culture. 
 
As mentioned above also spontaneous differentiation in OBs is typical for PSC [1]. So far the 
“hanging drops” method (Figure 6b) has been applied on PSC. Generation of OBs with this 
method is labour intense and the hereby yielded OBs are rather small. Another approach from 
ESC research is the spinning or shaking of bulk suspension cultures (Figure 6a) in non-
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adhesive dishes [83]. This generates large quantities of spheroids but the size of the resulting 
aggregates differs considerably. A third approach provides the possibility to produce large 
quantities of spheroids of a definite size by centrifuging down a certain cell number (Figure 
6c) in either falcon tubes or in well plates [84]. This method was transferred to PSC in this 
thesis. 
 
cell suspension
~250 000 cells
centrifugation
Centrifugation
C
3d
~600 cells /20µl
hanging drops
B
spinning / shaking
A
~400 000 cells/ml
 
 Figure 6: Three methods for generation of stem cell spheroids. 
 
5.3.2 RESULTS   
5.3.2.1 IMMANENT ENDOTHELIAL, EPITHELIAL AND STEM CELL CHARACTERISTICS OF PSC 
Immanent endothelial, epithelial and stem cell characteristics of PSC were investigated by 
cultivating cells in plain culture medium for 7 days. Specimens were then analyzed by RT-
PCR. Presence of select proteins was additionally determined by immunocytochemistry and 
FACS analysis. 
For investigating stem cell properties of PSC mRNA expression of the general stem cell 
markers NES, Oct 4 and c-kit and the more specific hematopoetic stem cell markers endoglin, 
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CD 45 and CD 71 was analyzed (Figure 7). Highest expression was found for NES and 
endoglin, followed by c-kit and CD 45. Also for Oct 4 a cognizable band was detected. 
Solely, presence of CD 71 could not be verified. 
 
PSC
NES
Oct
 4
endoglin
CD
 71
GAPDH
c
-kit
CD
 45
 
Figure 7: mRNA expression profile of stem cell markers in undifferentiated PSC. Samples were taken 
after 7 days of culture and analyzed by means of RT-PCR. 
 
Of major interest prior to differentiation experiments were also the immanent endothelial 
properties of PSC. Endoglin, CDH 5, VCAM 1, VEGFR 1, VEGFR 2 and vWF were chosen 
as significant markers. First of all occurrence of mRNA was determined by means of RT-PCR 
(Figure 8a). For classifying the expression of these markers in PSC HUVEC were drawn upon 
for reference (more to characterization of HUVEC in  5.4.2.1). Most pronounced band was 
found for endoglin, followed by VCAM 1 (shift of bands is explained in  5.4.1) and VEGFR 1. 
Also vWF was detected as a weaker, though visible, band. Merely, CDH 5 and VEGFR 2 
were not seen. The amount of VCAM 1 in PSC was comparable to that in HUVEC whereas 
all other bands were weaker than in control. 
For determining and also visualizing presence of the mRNA correlating proteins 
immunocytochemistry was applied. All proteins, whose mRNA were found by RT-PCR, 
could also be imaged by this method (Figure 8). 
For an additional quantification of this data FACS was applied as a third method. The two 
most pronounced endothelial proteins in PSC, endoglin and VCAM 1, were investigated by 
such means. Presence of both proteins was determined and statistically evaluated. Compared 
to control expression of endoglin was at 1600 % and VCAM 1 at 120 % (Figure 9). 
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Figure 8: mRNA expression profile of endothelial markers in undifferentiated PSC. Samples were taken 
after 7 days of culture and analyzed by means of RT-PCR (a) and immunocytochemistry (b-
e).  
 
Also the immanent epithelial characteristics of PSC were investigated. Therefore the markers 
K 7, K 8, K 18, K 19, CTNb1, ZO-1, CDH 1 and EpCAM were analyzed by RT-PCR (Figure 
10a). A549 served as an epithelial control. Most pronounced band in PSC was found for K 18, 
followed by K 7, CTNb1 and ZO-1. Clearly visible bands showed also K 8 and K 19, while 
CDH 1 and EpCAM were not detected. In PSC bands of K 18, K 19, CTNb1 and ZO-1 were 
comparable to those in A549, whereas bands of K 7 and K 8 were weaker as in epithelial 
control.  
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Figure 9: Expression of the endothelial proteins endoglin and VCAM 1 in PSC. Samples were taken after 
7 days of culture and analyzed by FACS. For statistical analysis mean fluorescence intensity 
(MFI), presented as median (range), are displayed.  
 
Since all investigated keratins were found as mRNA, panKeratin was analyzed at protein 
level. By means of immunocytochemistry all-over expression of this marker was clearly 
detected (Figure 10b).  
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Figure 10: Expression profile of epithelial markers in undifferentiated PSC. Samples were taken after 
7 days of culture and determined by means of RT-PCR (a) and for pankeratin also by 
immunocytochemistry (b).  
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5.3.2.2 INFLUENCE OF CULTURE ON DIFFERENT ECM ON MARKER EXPRESSION PROFILE OF 
PSC 
The choice of substrate has an impact on the development of the cells cultured upon them. 
Numerous publications [67, 68] show that depending on the cell type different substrates can 
trigger a certain direction of differentiation. Therefore, the influence a substrate has on a 
stem / progenitor cell is supposed to be characteristic of this cell type. 
The ECMs C I, C IV, FN, LN and PDL were selected for cultivating PSC upon. After 21 days 
of culture cells were analyzed for changes in their gene expression profile compared to PSC 
grown on TCP. Markers for stem cell, endothelial and epithelial qualities, which were prior 
used for a specific characterization after 7 days of culture, were investigated by means of RT-
PCR.  
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Figure 11: mRNA expression of stem cell, endothelial and epithelial markers of PSC. Samples were taken after 
21 days of culture on different ECM (C I, C IV, FN and LN) and analyzed by RT-PCR. PSC grown 
on TCP served as control. 
 
PSC seeded on PDL grew only insufficiently, which prevented further analysis of these 
samples. Apart from this singularity only small influence of matrices was observed in an 
altered expression of CDH 1, CDH 5 and ZO-1 (Figure 11). Whereas CDH 1 and CDH 5 
were not detected during characterization of PSC (7 days of growth prior to harvest), slight 
bands were observed after 21 days. Bands for CDH 1 were found on all substrates, however, 
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more distinguished on C I and C IV. CDH 5 was not found on LN, but on all other matrices. 
The primer ZO-1-iso, used for quantification of ZO-1 transcripts, distinguished between the 
two isoforms α- and α + (see Chapter  6). The ratio of the two isoforms remained constant on 
all substrates; however, the total amount of ZO-1 was reduced on C I. 
5.3.2.3 INFLUENCE OF AIR INTERFACE CULTURE ON PSC 
Apart from the substrate also the presence or lack of surrounding cell culture medium has an 
impact on development of cells. A culture system in which cells have access to the medium 
only from one direction can direct or maintain a certain way of cell differentiation [75, 85, 
86]. This can be achieved by exposing the upper side of the cells to air instead of medium, 
which is called Air Interface culture (AIF). 
 
a)
c)
conventional culture AIF
b)
d)
 
Figure 12: Light microscopic view of PSC morphology in conventional (a, c) and AIF culture (b, d) observed in 
top view (a, b) and in side view (c, d).  
 
PSC were grown for 7 or 21 days in the apical compartment of a Transwell® system either in 
a conventional culture, where cells were covered by medium, or in an AIF, where the medium 
of the upper compartment was removed after 2 days post-seeding. A light microscopic and 
histological examination was then performed. 
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After 7 days PSC in the conventional culture showed in top view (Figure 12a) a dense growth 
and homogenous distribution. In side view (Figure 12c) it was obvious that nearly all cells 
were not growing in monolayer but in two layers instead. In AIF PSC showed a different 
morphology. Top view (Figure 12b) revealed a wave-like texture, which consisted of two 
alternating structures. In the first area PSC had a compact and dense and, as in the 
conventional culture, a two-layer growth (Figure 12d). In the second area PSC displayed a 
monolayer and had a distinct stretched morphology. Histological examination after 21 days of 
culture showed identical results to samples taken after 7 days. 
5.3.2.4 SPONTANEOUS DIFFERENTIATION OF PSC IN ORGANOID BODIES 
A specific quality of ESC is the spontaneous differentiation within spheroids. The method of 
hanging drops is by far the most frequently used protocol for generation of spheroids of a 
certain size [87]. This protocol has already successfully been transferred to PSC [1], which 
also showed the characteristic of spontaneous differentiation in the thereby generated 
spheroids, called organoid bodies (OBs).  
 
d 6 d 9 d 23
a) b) c)
d) e)
d 23d 23
 
Figure 13: Formation of OBs after centrifugation of PSC. Histological cross section of OBs after 6, 9 and 
23 days of culture (a-c) and close ups of day 23 (d, e).  
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Since the hereby yielded OBs are comparatively small and differentiation therefore limited, an 
alternative method from ESC research using centrifugation [84] was applied. A suspension 
containing 250,000 PSC was centrifuged down. The resulting pellet rounded up over night 
and was detached from the tube by gentle shaking. Spheroids were observed for up to 
23 days. 
Already after 6 days the former pellet showed a three-layer histology, which could be seen 
over the whole observation period, consisting of surface, outer core and inner core (Figure 
13a). The surface is covered by a one-cell-layer, where the cells display a stretched 
morphology and a dense coherence. Cells in the core are either stretched or cuboidal. The 
outer core consists of very densely packed cells, whereas coherence between cells in the inner 
core is rather loose. Structures at day 9 resemble structures at day 6. After 23 days the inner 
core is subject of necrosis and no more single cells are detectable. In the outer core long and 
stretched cells alternate with dense cuboidal cells. Also areas are visible, that look like cross 
sections of tube-like structures. All in all the outer core has a very heterogeneous appearance. 
The surface layer consists of coherent stretched cells.  
5.3.3 DISCUSSION 
PSC are a rather new source of stem cells, described for the first time in 2004 [1]. During the 
course of this thesis only two publications [1, 78] dealt with human PSC and nearly no 
knowledge about their endothelial and epithelial properties had been gained. Therefore, a 
thorough investigation of stem cell, endothelial and epithelial characteristics was pivotal, 
before any differentiation experiment was carried out. This was necessary on one hand for 
determining the possible potential of the cells and on the other hand for detecting a successful 
differentiation. 
At mRNA level NES, Oct 4, endoglin, c-kit and CD 45 were detected. NES is regarded as a 
marker for neural stem cells [88]. Oct-4 is mostly found in the nucleus and is involved in the 
self-renewal of embryonic and adult stem cells [89]. Endoglin and CD 45 are characteristic 
for haematopoetic stem cells [90]. C-kit is not only found in haematopoetic stem cells but also 
in ESC [91]. By expressing these markers PSC display a pattern specific for stem and 
progenitor cells. Subsequent studies confirmed these findings and added Alkaline 
Phosphatase, CD 9, CD 29, CD 81, c-Myc, KLF-4, nanog and SOX-2 to the stem cell 
expression profile [92-94]. 
Undifferentiated PSC were also positive for endothelial lineage markers. VCAM 1, VEGFR 1 
and vWF were found, as well as endoglin, which is also regarded as a marker for stem cells 
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(see above). These markers are widely used for the identification of endothelial progenitor 
cells and for detecting successful differentiation of stem cells.  
Epithelial commitment of PSC is recognizable by their immanent mRNA expression of 
CTNβ1 and ZO-1 and of the keratins 7, 8, 18 and 19 and of panKeratin at protein level [95] . 
The existence of ZO-1 in PSC was unexpected. A former study detected this protein in the 
pancreas, but only in the pancreatic ducts [96]. In the acinary parts, where PSC are harvested 
from, existence of this marker could not be verified. ZO-1 is not only characteristic for the 
epithelium, where it is mainly found in the tight junctions. Furthermore, it modulates cell 
proliferation in mature cells [97] and also cell proliferation and differentiation during 
ontogenesis [98, 99] (see also Chapter  6). Therefore, the finding of ZO-1 in PSC underlines 
once more their stem cell character. Even more unexpected was the presence of panKeratin at 
protein level in undifferentiated PSC. In 2004 Kruse et al. [1] described an expression of 
cytokeratin at protein level, which was found at the outer borders of OBs, while the inner 
mass lacked any presence. Since panKeratin is found in undifferentiated PSC, the protein 
expression apparently ceases during course of maturation. This demonstrates that 
differentiation into a certain cell type makes PSC loose their immanent epithelial 
characteristics. Later studies showed an opposed but not contradictory view of keratin 
expression. Gorjup et al. [92] did not detect CK 14, 15, 16 or 19 at protein level, whereas 
Ciba et al. [100] and Petschnik et al. [94] could verify mRNA expression of CK 18 at mRNA 
and protein level and of panKeratin at protein level.  
As it has been reported frequently that cultivation of stem cells on ECM [68, 101-104] can 
influence differentiation, the matrices C I, C IV, FN, LN and PDL were investigated for their 
impact on PSC. Most variations in marker expression were small, only CDH 1 and CDH 5 
showed distinctive alterations compared to the characterization performed before. PSC 
analyzed then did not display any of the two cadherins. New expression in this experiment is 
possibly due to the longer cultivation period. While PSC for characterization were allowed to 
grow for 7 days only, PSC for the later experiments were cultured for 21 days. During a 
longer cultivation cells keep on proliferating, density between cells increases and cells have 
more time and opportunities to build out communication with their neighbours. This direct 
and close cell-cell contact has often been proofed to be decisive for differentiation of stem and 
progenitor cells. Exemplary is the production of EBs from ESC in hanging drops [105], which 
has become a standard procedure for inducing spontaneous differentiation. This cultivation 
method had also the same effect on PSC [1, 79], which formed OBs, in which tissues from all 
germ layers were detected. Even in “-D cultures cell-cell contacts have an impact on cell  
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Table 2: Expression of markers at mRNA and protein level of human PSC. 
 
Marker source / meaning mRNA protein reference 
albumin endoderm pos - [92, 93] 
alk. phosphatase stem cell  pos - [92, 93] 
amylase endoderm / pancr. enzyme pos - [92, 93] 
BMP-2 bone / cartilage pos - [92] 
CD 9 stem cell pos pos [92-94] 
CD 15 (SSEA-1) stem cell - neg [92-94] 
CD 29 stem cell - pos [92, 93] 
CD 31 (PECAM-1) blood / endothelium - neg [92] 
CD 34 haematopoetic stem cell - neg [92, 93] 
CD 44 T-cell / cancer - pos [92, 93] 
CD 81 B cell activation / cancer - pos [92, 93] 
CD 90 (Thy-1) haematopoetic stem cell - pos [92] 
CD 105 (endoglin) haem. stem cell / endothelium - pos [92, 93] 
CD133 (PROM-1) haematopoetic stem cell - neg [92] 
CK 14, 15, 16, 19 epithelium - neg [92] 
CK18 epithelium pos pos [94, 100] 
c-kit stem cell pos neg [92, 93] 
c-Myc stem cell pos - [94] 
GFAP central nervous system pos - [93] 
integrin α6 stem cell pos - [93] 
Ki67 proliferation pos pos [94] 
KLF-4 stem cell pos - [94] 
MEF2D Transcription factor pos - [94] 
MHC 1 cell surface molecule - pos [92] 
MHC 2 Immune system - neg [92] 
nanog stem cell (pos) - [92] 
nestin stem cell pos pos [92-94, 100] 
neuro filaments neuron pos pos [93, 94, 100] 
Oct4 stem cell pos [92, 94], neg [93] pos [92-94] 
PGP 9.5 neuron pos - [92, 93] 
PPARγ glucose metabolism pos - [94] 
S100β nervous system pos - [94] 
Sox2 stem cell pos pos [94] 
SPP1 bone pos - [94] 
troponin T2 mesenchym pos - [93] 
vigilin protein synthesis pos pos [94] 
vWF endothelium pos - [94] 
α-SMA mesenchym pos pos 
[92-94, 100, 
106] 
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differentiation [107] and even cell density can influence the fate of stem cells. While in high 
density cultures cortical stem cells differentiated to neurons, astrocytes and oligodendrocytes, 
low density cultures led to smooth muscle cells [108]. Therefore, the influence of cultivation 
period and density is highly probable and might lead to an enhanced expression of CDH 1 and 
CDH 5 and thereby giving rise to endothelial- and epithelial-like cells.PSC were also 
subjected to AIF culture. This is a culture method which is i.e. applied in lung epithelial 
research. Lung epithelial cells differ significantly in morphology, function and phenotypic 
when cultured in AIF instead of conventional culture. Calu-3 cultured by AIF display a 
morphology very similar to airway epithelium [109]. Cells grow to a more columnar 
epithelium with a rugged apical topography and even occasionally cilia-like structures are 
formed. A changed morphology was also visible for PSC cultured by AIF culture. Instead of a 
continuous two-layer growth in conventional culture, areas with stretched one-layer PSC 
alternated with densely packed two-layer cells, resulting in a wave-like morphology. Calu-3 
also produce greater amounts of glycoprotein in AIF culture [109]. Further investigations on 
PSC might also reveal such outcome of the two culture methods on functional differences. 
Apart from application in original lung and skin epithelial research AIF culture also found 
successfully its ways into stem cell research. Keratinocytes derived from hESC [81] were 
cultured on dermal constructs with collagen gels and human dermal fibroblasts. hESC- 
derived and primary keratinocytes showed a similar induced stratification of surface 
epithelium in this AIF model.  
Formation of the already mentioned OBs was achieved during this thesis by a method 
applying centrifugation. Thereby generated spheroids, originating from 250,000 cells, were 
larger than OBs resulting from the established method of hangings drops [1], originating from 
600 cells. The spheroids generated by centrifugation displayed a three-layer morphology of 
surface, outer and inner core. The same structures are known from EBs. There the surface 
layer consists of epithelial-like cells and a dense ECM [110]. In the inner cell mass also an 
ECM deposition takes place. Cells at the outside of this basal lamina stay viable, while cells at 
the interior undergo apoptosis. This results in a fluid-filled cavity at the inner core of the EBs 
[111]. Cells in the outer core of the EB differentiate into cell types from all three germ layers 
[112]. Also OBs from PSC generated by centrifugation showed this epithelial-like structure at 
the surface and the beginning of cell death from day 23 in the inner cell core. The outer cell 
core showed heterogeneity of structures and morphologies. A closer histological investigation 
was not performed, but the microscopic insights already suggest the existence of a wide range 
of cell types and tissues within the so generated OBs. 
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5.4 ENDOTHELIAL POTENTIAL OF PSC AND MSC 
5.4.1 INTRODUCTION 
5.4.1.1 BACKGROUND 
The endothelium is the innermost single cell layer of blood and lymphatic vessels. It forms an 
interface between the circulating blood or lymph and the rest of the vessel wall. It is separated 
from the outer vessel walls by a basal lamina. These two layers build up the intima of the 
vessel wall, which is present in every single vessel (Figure 14). Depending on the size and 
function of the vessels their wall can additionally consist of a layer of smooth muscle cells 
(media) and of connective tissue (adventitia).  
 
 
Figure 14: Schematic structure of epithelium. Adopted from [113]. 
 
A single endothelial cell has a diameter of approximately 20 µm and a thickness between 0.1 
and 1 µm. The entire vascular endothelium of the human body, however, weighs between 1 
and 1.5 kg, comparable to other inner organs like liver.  
For a long time endothelium has been regarded as the inner lining of vessels only. Today it is 
known to be involved into numerous physiological processes: regulation of blood pressure, 
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angiogenesis, blood clotting, oxidation processes, arteriosclerosis and inflammation. Most 
obvious function remains the barrier function between the vessel lumen and the surrounding 
tissue. Depending on the location of endothelium its permeability varies considerably. While 
the endothelium at the blood-brain-barrier is a very “tight” one, using highly selective 
transport mechanisms, endothelium in the liver is even permeable for cells.  
The loss of proper endothelial function is often observed in cardio-vascular diseases like 
arteriosclerosis, coronary artery disease, diabetes mellitus, hypertension and 
hypercholesterolemia. Also smokers and patients with rheumatoid arthritis suffer frequently 
from endothelial dysfunction. 
Adult stem cells like MSC and PSC may be an alternative source to endothelial progenitor 
cells for generating autologous endothelial cells for usage in clinical therapies. They could be 
the base for the repair of injured blood vessels or for the neovascularisation of ischemic 
tissues. Also vascular prostheses could be lined with an autologous endothelium.  
5.4.1.2  APPROACHES FOR ENDOTHELIAL DIFFERENTIATION OF PSC AND MSC 
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Figure 15: Schematic diagram of the three main protocols for endothelial differentiation of stem cells. 
 
For differentiating adult stem cells into endothelial-like cells, various protocols are found in 
literature. Most of them apply as a triggering factor either VEGF alone [77, 114] or VEGF in 
combination with other growth factors [115-118], first of all bFGF. VEGF is a potent agent to 
induce endothelial differentiation in adult and ESC and bFGF is known to support 
mesenchymal commitment and also to enhance endothelial differentiation in combination 
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with VEGF [118-121]. Therefore, several protocols with varying concentrations of VEGF in 
combination with bFGF were applied.  
Stem cells were incubated with 10, 20 and 50 ng/ml VEGF for 3, 7 and 14 d to determine the 
optimal concentration of the growth factor and also the desired time for differentiation. 
HUVEC and stem cells, cultured in maintenance medium only, were used as control.  
In a further approach 20 ng/ml bFGF and 50 ng/ml VEGF were applied for 21 d either 
simultaneously or with a temporary offset (7 d bFGF, then 14 d VEGF). Stem cells were also 
cultured in ECGM, a medium applied for maintenance and proliferation of endothelial cells, 
which contains an optimized cocktail of growth factors. As known to be of importance, also 
the influence of ECM was considered. All protocols were applied to cells grown on TCP and 
on FN.  
As a third approach FBS content of medium was reduced prior to incubation of stem cells 
with growth factors in order to increase responsiveness of stem cells. This ‘‘serum 
starvation’’ of cells is a common tool e.g. in directed myofibroblastic differentiation [122]. It 
is known to increase responsiveness to subsequently added differentiating agents. Even a 
patent is pending, which applies serum starvation of MSC to yield somatic pluripotent cells 
[2]. Hence, stem cells were cultured for 48 h in DM containing 0.1 % FBS prior to incubation 
with DM containing 20% FBS supplemented either with VEGF or bFGF / VEGF for 12 d.  
All samples were analyzed by RT-PCR for expression of the endothelial markers PECAM 1, 
CD34, endoglin, VCAM 1, CDH 5, VEGFR 1, VEGFR 2 and vWF. 
Beside determination of mRNA and protein expression also a functional assay was 
performed. The formation of capillaries in semisolid medium is considered as a proof for 
endothelial potential [77]. Therefore, the ability of stem cells to develop such tubes was 
investigated by an in vitro angiogenesis assay. Cells were seeded on top of ECMatrix and tube 
formation was monitored for 8 hours. In order to examine, whether stimulation with growth 
factors could enhance the potential of forming vessel-like structures, stem cells were cultured 
for 7 d with VEGF or a combination of bFGF/VEGF before performing an in vitro 
angiogenesis assay. HUVEC served as positive and Caco-2 as negative control. 
5.4.2 RESULTS 
5.4.2.1 CHARACTERIZATION OF HUVEC 
For determining developing endothelial features in stem cells, a control is needed, which 
displays all the essential markers distinctively. HUVEC were chosen for this purpose. Two 
different sources of HUVEC were used. The first one was purchased form PromoCell, the 
second one had been isolated in the institute (Biophatmaceutics and Pharmaceutical 
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Technology, Saarland University). For using cells from both sources in parallel, they had to 
be investigated for comparability of endothelial marker expression. This was performed by 
using RT-PCR analysis of the markers CD 34, CDH 5, endoglin, PECAM 1, VCAM 1, 
VEGFR 1, VEGFR 2 and vWF. 
Both batches displayed all markers and showed a nearly identical expression profile (Figure 
16). HUVEC from both origins had equal bands for PECAM 1, endoglin, CDH 5, VEGFR 1, 
VEGFR 2 and vWF. HUVEC from PromoCell showed a stronger expression for CD 34. The 
analysis of VCAM 1 showed two very close bands for the corresponding isoforms of the gene 
transcript.  
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Figure 16: mRNA expression profile of endothelial markers in HUVEC purchased from PromoCell 
and HUVEC isolated in the institute. 
 
5.4.2.2 ENDOTHELIAL POTENTIAL OF PSC AND MSC 
Indifferent of applied differentiation approaches ( 5.4.1.2) all PSC samples displayed 
endothelial markers endoglin, VCAM 1, VEGFR 1 and vWF at mRNA level, while 
PECAM 1, CD 34 and VEGFR 2 were not expressed (Figure 17). No protocol did stimulate a 
significant stronger expression of any endothelial marker. 
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Figure 17: Influence of endothelial differentiation protocols on PSC. Stem cells were cultured with 10, 20 and 
50 ng/ml VEGF for 3, 7 and 14 days (a), with 20 ng/ml bFGF and 50 ng/ml VEGF either 
simultaneously or successively and with ECGM for 21 days on TCP or FN (b), and after starving of 
PSC with 50 ng/ml VEGF and with 20 ng/ml bFGF and 50 ng/ml VEGF for 12 days (c). mRNA 
expression was determined by RT-PCR and PSC grown in plain DM and for the last experiment (c) 
also PSC which had not undergone starving served as controls. 
 
Also MSC showed an unaltered expression of endoglin, VCAM 1 and vWF. VEGFR 2 and 
PECAM 1 were expressed so weakly, that no alteration was distinguishable. CD 34 was 
clearly detected for the samples on TCP and FN, which were incubated in plain medium and 
medium containing VEGF alone or time-delayed bFGF and VEGF. Expression with bFGF 
and VEGF simultaneously and ECGM was considerably reduced. Sample set of starved MSC 
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did not show any bands for this marker. Expression of VEGFR 1 was found in all MSC 
samples. Most specimen displayed an equally strong expression of two alternative transcripts 
[123], which can be seen best for the starving set of samples. Solely MSC incubated with 
ECGM showed bands for the shorter transcript only (Figure 18).  
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Figure 18: Influence of endothelial differentiation protocols on MSC. Stem cells were cultured with 50 ng/ml 
VEGF, with 20 ng/ml bFGF and 50 ng/ml VEGF either simultaneously or successively and with 
ECGM for 21 days on TCP or FN (a), and after starving of MSC with 50 ng/ml VEGF and with 20 
ng/ml bFGF and 50 ng/ml VEGF for 12 days (b). mRNA expression was determined by RT-PCR and 
MSC grown in normal culture medium and for the second experiment (b) also MSC which had not 
undergone starving served as controls. 
 
The in vitro angiogenesis assay showed an extensive tube formation for the positive control 
HUVEC (Figure 19b) and no such behavior for the negative control Caco-2 (Figure 19a). PSC 
(Figure 19c) and MSC (Figure 19d) also developed capillaries, which had their maximum 
extent after 8 hours. Compared to HUVEC fewer stem cells contributed to formation of 
capillaries, while indifferent cells could be distinguished by their round shape. However, the 
capillary structures formed by stem cells were fewer but also bigger, especially those formed 
of PSC; in comparison to those developed by HUVEC. Stem cells additionally treated with 
growth factors showed a tube formation comparable to that of untreated cells. 
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Figure 19: in vitro angiogenesis assay: PSC (c) and MSC (d) were plated on ECMatrix™ and showed an 
extensive tube formation with strongest occurrence after 8 h (big pictures; small once show state 
after 2h). Caco-2 (a) served as negative and HUVEC (b) as positive control. 
 
5.4.3 DISCUSSION 
Endothelial progenitor cells, isolated from human blood, promise a potential for the therapy 
of myocardial infarction [124] and peripheral arterial disease [125]. However, blood-derived 
endothelial progenitor cells are difficult to obtain in sufficient amounts. Alternatively, other 
human stem cells like MSC and PSC may be used for yielding endothelial-like cells for 
application in medical therapy.  
All protocols applied in this study had shown in literature to successfully differentiate stem 
and progenitor cells and in one case even MSC [77] to endothelial-like cells. An exact transfer 
of a protocol from one cell type to another is nearly never effective. Minor or even major 
adaptations are mostly required to optimize the protocol accordingly. In this case PSC were in 
the beginning treated accordingly to a protocol for MSC by Oswald et al. [77] applying VEGF 
alone. As no differentiation was achieved with different VEGF concentrations the medium 
was topped off with bFGF. Both growth factors were applied either simultaneously or with a 
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time shift. PSC were also incubated in ECGM, which contains additionally to VEGF and 
bFGF Ascorbic Acid, Epidermal Growth Factor, Heparin, Hydrocortisone and Insulin-like 
Growth Factor. Still no differentiation was achieved. Furthermore, PSC were grown upon FN 
as an endothelium-supporting substrate. The last approach applied a method known as ‘serum 
starvation’, where responsiveness of stem cells to differentiating factors is increased by 
incubation in a low serum medium for two days. However, no differentiation at mRNA level 
was recognizable. Although PSC showed before their ability to spontaneously differentiate 
into cell types from all three germ layers [1] endothelial cells in particular were not detected 
then and since. Even established differentiation approaches could not successfully be 
transferred to PSC. No differentiation was detectable. However, the apparently obvious 
conclusion, that PSC are utterly not able to generate endothelial cells, is weakened by the also 
performed functional assay. There PSC displayed an ability, which is considered as an 
endothelial characteristic [77, 126, 127]. On a semi-solid matrix they form tube-like 
structures. This is typical for endothelial cells, whose one task among others is to build up 
new vessels by angiogenesis. This process is essential during embryogenesis, growth and 
development phases and in wound healing and granulation processes [128]. PSC displayed 
this ability indifferent of incubation with VEGF but as an immanent feasibility. Additionally, 
PSC display already in their undifferentiated state a range of endothelial markers, namely 
endoglin, VCAM 1, VEGFR 1 and vWF at mRNA (see Figure 8 and Figure 9 in Chapter 
 5.3.2.1). mRNA expression profile and functionality, therefore, suggest the possibility, that 
PSC may be differentiated to endothelial cells by the right protocol.  
Some time after differentiation experiments with PSC had started, MSC were brought in. 
Endogenously MSC showed the endothelial markers endoglin, VCAM 1, vWF, and also 
weaker VEGFR 1 and VEGFR 2 after 14 and 21 days of culture in plain stem cell medium 
without any differentiating agents. CD 34 was not or nearly not detectable for MSC samples, 
which were starved and for samples which were incubated in ECGM or with bFGF and 
VEGF simultaneously. Starvation samples were cultured in total for 14 and all other samples 
for 21 days. Apparently the longer cultivation period enhances expression of this marker, 
even though ECGM and the simultaneous presence of bFGF and VEGF minimize this effect. 
This observation is in accordance to findings, which report a commitment to endothelial 
lineage, when MSC are cultured in high density (see below) [126]. MSC displayed like PSC 
the ability to build vessel-like structures in an in vitro angiogenesis assay. Again, marker 
expression profile and functionality are indicating a high endothelial commitment. 
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The same protocols, which had been used for PSC, were also applied for MSC. Also for these 
stem cells no differentiation was observed. This was surprising, since not all of the protocols 
had been transferred from other stem cell types on MSC. The first approach had been 
identical to a publication by Oswald, where he claims to differentiate human adult MSC to 
endothelial-like cells by means of VEGF. He was the first one to describe such an apparently 
successful differentiation. This raises the question, why the transfer to our MSC was not 
successful. Three options are to be considered. (1) Failures during carrying out of experiments 
or in handling of cells. Mistakes in handling are always possible, but risk was minimized by 
sticking to standard routines and to the described protocol. (2) Marker expression and also 
potential of MSC can differ considerably depending on the source of origin [129]. Although 
both sorts of MSC were isolated from bone marrow, age of donor and also passage numbers 
are known to be of influence. (3) Original protocol was not accurate, either protocol was 
incomplete or differentiation was not achieved. Oswald was and is the only one who reported 
a differentiation of human adult MSC to endothelial-like cells by incubating the confluent 
stem cells for 7 days with 50 ng/ml VEGF. In the meantime more papers dealt with this 
subject and all applied much more complex protocols. They describe a combination of VEGF 
and bFGF [116, 118, 130], of VEGF, Epidermal Growth Factor and Hydrocortisone [131], 
complex growth cocktails [132], substrates like FN or MatrigelTM [117], co-culture systems 
[133, 134] or even in vivo conditions [130]. Furthermore only some of them are dealing with 
human MSC [118, 133, 135], while the others apply rat [132, 134] or mouse [130] cells, some 
of them even of fetal origin [116]. So, how managed Oswald his differentiation and did there 
remain any ambiguity? Oswald differentiated MSC by incubating confluent MSC for 7 days 
with VEGF. Apparently he did not run a negative control of MSC in plain medium treated 
otherwise identically. Instead he compared differentiated cells with undifferentiated MSC, 
which never reached confluence during cell culture routine. He failed to ensure by his 
experimental design that not again density of cells plays the main role for the commitment of 
MSC (see below) [126]. Oswald also reported the detection of Weibel-Palade bodies in 
differentiated MSC. These organelles are found only in endothelial cells, where they store 
vWF and P-selectin. In the immunofluorescence, he takes as a proof for existence of Weibel-
Palade bodies, vWF is entirely distributed within the cytoplasm of the cell, while the actual 
storage organelle is empty. Even if the body membrane was disrupted by staining procedure, 
some of the vWF must have remained within the organelle. Whether the detected structure 
was a Weibel-Palade body is therefore questionable. All in all the line of evidence Oswald 
presented is not immaculate. However, it is undeniable that treated MSC displayed 
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endothelial markers at protein level and functional characteristics by forming tube-like 
structures on semisolid matrix. 
Since 2000 publications also dealt with cell-cell contact and its influence on behavior of 
human MSC. Conditioned medium, which belongs to methods of indirect coculture (see 
Chapter  5.5.1.2), of HUVEC stimulated proliferation of MSC [136]. The same effect was seen 
for indirect and direct coculture of the same cell types, while effect of direct coculture was 
significantly stronger [137]. In 2005 Wu et al. [133] even demonstrated in an ex vivo model a 
differentiation to endothelial-like cells, when human MSC were simultaneously cocultured 
with HUVEC directly and with smooth muscle cells indirectly. An endothelial maturation 
without any coculture was reported by Liu [135]. After 3 weeks of culture in an endothelial 
growth medium, MSC displayed endothelial markers and also formed tube-like structures 
upon MatrigelTM. However, expression profile at mRNA and protein level as well as 
morphology did not comply with cord blood derived endothelial progenitor cells. In 
2009Chen was able to differentiate umbilical blood and also bone marrow derived MSC to 
endothelial-like cells by means of VEGF, Epidermal Growth Factor and Hydrocortisone 
[131]. However, in  2012 culture of MSC at high density was the first approach to report not 
only expression of endothelial markers and tube-formation, but also an altered morphology of 
human MSC [126]. This happened without any other stimulating agents like differentiation 
factors or a second cell type. Solely close and long contact of MSC to their neighbors 
triggered this maturation. This development was traced back to Notch signaling, which is 
known to be involved in many processes of cell-cell communication and also in angiogenesis 
[138]. High density MSC displayed high levels of Notch. They also secreted VEGF, which 
was suppressed after incubation with a Notch signaling inhibitor. Furthermore, siRNA 
knockdown of Notch receptors 1, 2 or 3 decreased VEGF secretion and VEGFR1 expression. 
Thus, the significance of Notch signaling in the differentiation of MSC to endothelial 
progenitor like-cells was demonstrated. 
Still, the complex process during differentiation of progenitor or stem cells to endothelial cells 
has not been decoded yet. For each type of cell a particular protocol has to be developed 
before a differentiation can be achieved. In this study neither PSC nor MSC could be 
differentiated along the endothelial lineage. However, both cell types express endogenously 
endothelial markers at mRNA level and also display the typical endothelial characteristic of 
tube formation on a semi-solid matrix. Both properties suggest a high endothelial 
differentiation potential. So far just the right protocol is missing.  
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5.5 EPITHELIAL POTENTIAL OF PSC AND MSC 
5.5.1 INTRODUCTION 
5.5.1.1 BACKGROUND 
Epithelia are tissues consisting of closely packed cells, which line all free surfaces of the body 
and also the internal body cavities. Epithelia have no vessels but exist on an underlying layer 
of vascular connective tissue, from which they are separated by a basal lamina existing of 
ECM. Epithelia are classified by their number of cell layers and the shape of cells in their 
surface layer. Simple epithelia consist of only one layer of cells, stratified epithelia of two or 
more layers. According to their height and shape cells are either squamous (scale- or plate-
like), cuboidal or columnar. All epithelial cells are polar, meaning that there are two sides to 
be discriminated. The apical side faces the lumen, the basolateral side the basal lamina and 
thereby the underlying tissue. Both sides differ considerably in structure and functionality 
depending on the epithelial cell type. The two primary functions of epithelium are protection 
and regulation. Underlying tissues are protected against physical trauma, radiation, 
dehydration and toxins, and the transport of substances between the underlying tissues and the 
body cavity is regulated. Depending on the type of epithelium it also has a secretory function 
of either delivering hormones into the blood stream or secretion of enzymes, mucus or sweat 
by epithelial glands. 
The lung epithelium can roughly be discriminated into bronchial and alveolar epithelium. The 
bronchial epithelium comprises seven different cell types: goblet cells, basal cells, ciliated 
cells, brush cells, serous cells, Clara cells, and neuroendocrine cells [139]. The alveolar 
epithelium consists of mainly two cell types. Alveolar cell type I is squamous and covers 
approximately 95% of the alveolar surface accomplishing the gas transport. Alveolar cell type 
II is cuboidal and secrets surface active substances [140].  
There is a big need of adequate models of lung epithelial tissue for in vitro screening of 
pharmaceutical substances. Usage of cell lines is widely spread but they are neither optimal 
for cytotoxicity testing nor transport studies. Experiments with human primary cells resemble 
in vivo conditions much better. Unfortunately, sources are scarce and only few laboratories 
perform isolation of primary lung epithelial cells. Moreover, these cells are complex in 
maintenance and suffer from a very limited life span [75, 86, 141]. Human adult stem cells 
may be a promising tool for generating epithelial cells in bigger scale for these needs. This 
study, therefore, focused on the human stem cells PSC and MSC and their ability to give rise 
to lung epithelial-like cell types for future application in in vitro testing. 
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5.5.1.2 APPROACHES FOR EPITHELIAL DIFFERENTIATION OF PSC AND MSC 
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Figure 20: PSC or MSC were either cocultured with the epithelial cell lines A549 or Calu-3 indirectly (in 
conditioned medium), directly (upon fixed cells) or with a combination of both methods. 
 
Unlike for endothelial differentiation there are so far no established protocols found in 
literature for differentiating stem cells into lung epithelial like cells by means of soluble 
factors. A further commonly used approach for influencing differentiation into a certain cell 
type is the cocultivation of stem and progenitor cells with fully differentiated cells [142-146]. 
Up to now no such model for epithelial cells has been established. Therefore, several 
approaches were tried in this thesis comprising different coculture systems. In indirect 
coculture both cell types are physically separated and communication is mediated by soluble 
factors only [147]. For example the application of conditioned medium is counted to indirect 
co-cultures [146]. Conditioned medium is generated by culturing the mature cell type in its 
usual growth medium. After a certain time the medium is removed, filtered and blended with 
fresh medium, which is typically the culture medium of the respective stem cells. Stem cells 
are then allowed to differentiate within this conditioned medium. In direct cocultures stem 
cells are cultivated with a second cell type [143, 144, 148], which allows for direct contact 
with the proteins and structures of the cell membrane. Cells of this mature cell type can either 
be fully viable, hindered in proliferation or even fixed. 
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In this study PSC were cocultured with the human lung epithelial cell lines A549 and Calu-3, 
which are both derived from carcinomas. A549 originate from an adenocarcinoma of a 58-
year old Caucasian male [149, 150]. They are widely used as an in vitro model of alveolar cell 
type II for investigating drug metabolism. Calu-3 are an adenocarcinoma cell line derived 
from a 25-year old Caucasian male. They are commonly applied as a model for bronchial 
epithelial cells in drug metabolism and transport studies [151, 152]. 
Three different approaches were applied: firstly, the influence of medium conditioned by 
epithelial cells, secondly, the impact of the surface of fixed epithelial cells and thirdly, a 
combination of both methods. Stem cells cultivated on tissue culture plates (TCP) and in 
normal cell culture medium served as control. 
5.5.2 RESULTS 
5.5.2.1 CHARACTERIZATION OF EPITHELIAL CELL LINES AND EPITHELIAL PRIMARY CELLS 
Due to the lack of established protocols with soluble factors the lung epithelial cell lines A549 
and Calu-3 were used for triggering epithelial differentiation in stem cells either by using their 
secreted growth factors or their cell surface (Chapter  5.5.1.2).  
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Figure 21: mRNA expression of epithelial markers in the lung epithelial cell lines A549 and Calu-3 and 
in the primary lung epithelial cells hAEpC (isolation 292 and 294). Samples were analyzed 
by means of RT-PCR. 
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For analyzing how far these cell lines resemble primary cells, they were compared to cells 
freshly isolated from human lung, called hAEpC (human alveolar epithelial cells)  
[75]. Primary cells from two different isolations (hL 292 and 294) were used for detecting 
possible inter-batch variations. All cells were investigated for the expression of the lung 
epithelial markers ZO-1, CTNβ1, AQP 1, EpCAM, CC 10, SPB, SPC and CDH 1 at mRNA 
level. 
All cell types showed similar strong bands for ZO-1, CTNβ1, EpCAM and CDH 1. AQP 5 
was still clearly detectable in Calu-3 and hAEpC, while the corresponding band in A549 was 
nearly not visible. SPB, SPC and CC 10 were only found in hAEPC. While SPB and SPC 
were strongly expressed in the primary cells, CC 10 showed only weak bands. 
5.5.2.2 EPITHELIAL POTENTIAL OF PSC 
As shown earlier [146] soluble factors secreted by fully differentiated cells can have an 
impact on the fate of stem cells or progenitor cells. Therefore, the influence of conditioned 
medium of A549 and Calu-3 on the expression of the epithelial markers CDH 1, EpCAM, 
AQP 5, CTNβ1 and ZO-1 at mRNA and protein level within PSC was investigated (Figure 
22a). After 21 days of culture ZO-1, CTNβ1 and EpCAM showed a similar expression for all 
samples, while AQP 5 was not detected (bands visible in the gel result from unspecific 
binding. If the amount of AQP5 was sufficient, only one clear band was visible, as can be 
seen in Figure 22b). However, for CDH 1 an influence was obvious. Whereas PSC cultivated 
in unconditioned medium showed a distinct band for CDH 1 PSC in conditioned medium 
displayed no expression.  
In order to investigate the trigger of the surface of dead epithelial cells on the differentiation 
of stem cells, A549 and Calu-3 were fixed before stem cells were seeded on top of them. One 
part of stem cells was additionally cultured in conditioned medium, while the second part was 
incubated in unconditioned medium. Stem cells in normal culture medium on TCP and also 
fixed and unfixed epithelial cells served as controls. After 12 days of culture epithelial cells 
were no longer visible but were removed by stem cells overgrowing them. mRNA and protein 
content in the samples of fixed epithelial cells was not detectable, which confirms that 
analyzed mRNA and protein originated from stem cells only. All investigated markers were 
expressed by controls of unfixed epithelial cells, although the band of A549 for AQP 5 was 
only weak (Figure 22b). PSC showed a comparable expression of ZO-1, CTNβ1 and EpCAM 
for all samples, while AQP 5 was not visible. PSC in normal DM on TCP did not display 
CDH 1. The same behavior was shown by PSC cultivated on fixed Calu-3. However, CDH 1 
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expression in PSC grown on fixed A549 was increased independent on incubation with 
conditioned or unconditioned medium.  
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Figure 22: mRNA expression of epithelial markers in PSC after application of epithelial differentiation 
protocols. Samples were taken after PSC were cultured on TCP (a) and on fixed A549 and Calu-3 
(b) with conditioned or unconditioned medium of A549 and Calu-3 for 12 days and were analyzed 
by means of RT-PCR. Untreated PSC, A549 and Calu-3 served as control (C).  
 
5.5.2.3 EPITHELIAL POTENTIAL OF MSC 
Firstly, the influence of conditioned medium was investigated. At mRNA level (Figure 23a) 
MSC control showed bands for all markers, although expression of AQP5 was very weak. 
Expression of CDH 1 stayed constant for MSC cultured in unconditioned medium (+ A549 
uncond / + Calu-3 uncond), but vanished for MSC incubated in conditioned medium of either 
A549 or Calu-3 (+ A549 cond / + Calu-3 cond). Bands for ZO-1, CTNβ1, EpCAM and 
AQP 5 stayed mainly constant. Only the expression of EpCAM in MSC + Calu-3 cond 
became weaker and the expression of AQP 5 in MSC + A549 uncond grew more intense. At 
protein level (Figure 23c) MSC control expressed also AQP5 and EpCAM, however, the band 
for CDH 1 was very weak. As already seen at mRNA level the expression of CDH 1 in MSC 
+ uncond was very intense, while bands for MSC + cond were very weak. Expression of 
EpCAM and AQP 5 was nearly invariable.  
Secondly, differentiation triggered by the surface of fixed epithelial cells was investigated. At 
mRNA level (Figure 23b) MSC control displayed CDH 1 and EpCAM but nearly no AQP 5. 
For CDH 1 MSC + A549 fix + cond showed a distinctively triggered expression and MSC + 
Calu-3 fix + cond and MSC + Calu-3 fix + uncond displayed nearly no expression at all. In 
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MSC + Calu-3 fix + cond the band for EpCAM was increased, while the other bands did not 
vary. Nearly all MSC samples showed a higher expression of AQP 5 compared to control 
apart from MSC + Calu-3 fix + cond. At protein level (Figure 23d) MSC control displayed 
neither CDH 1 nor AQP 5, but EpCAM in very small amounts. Apart from the Calu-3 control 
other samples showed solely hardly visible bands for EpCAM. Expression of AQP 5 was 
weak but visible for all MSC samples in particular for those + A549 fix. However, both 
samples of MSC + A549 fix + cond, MSC + A549 fix + uncond showed an intelligible 
expression of CDH 1. MSC samples cocultured with Calu-3 showed also an expression even 
though very weak.  
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Figure 23: mRNA (a, b) and protein expression (c, d) of epithelial markers in MSC after application of protocols 
for epithelial differentiation. mRNA samples were analyzed by means of RT-PCR and protein 
samples by means of Westernblot. MSC  were cultured on TCP (a, c) and on fixed A549 and Calu-3 
(b, d) with conditioned or unconditioned medium of A549 and Calu-3 for 12 days. Untreated PSC, 
A549 and Calu-3 served as control (C). 
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Finally, an immunocytochemical investigation for CDH 1 was performed in order to evaluate 
the localization of this protein in the native cells. Exemplary the results for Calu-3 and MSC 
control and for MSC + Calu-3 cond and +Calu-3 uncond are shown (Figure 24). Calu-3 
control showed a distinct accumulation of CDH 1 at the cell membrane. The same could be 
shown for all MSC samples, which had already an intelligible protein expression determined 
by Westernblot. The MSC control displayed no immunofluorescence for CDH 1 at all. And 
also the samples of MSC +Calu-3 cond and MSC + A549 fix + uncond showed only a diffuse 
binding of the antibody. MSC control displayed no expression at all. All samples, which had 
already a distinct protein expression determined by Westernblot, showed a similar 
accumulation of CDH 1 at their membrane.  
 
Calu-3
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MSC + Calu-3 cond
MSC + Calu-3 uncond
control MSC
 
Figure 24: immunocytochemical determination of the expression of CDH 1 at protein level in MSC, 
which were cultured with conditioned and unconditioned medium of Calu-3. Calu-3 and 
MSC in normal culture medium served as control. 
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5.5.3 DISCUSSION 
So far there is no established protocol to differentiate human adult stem cells into lung-
epithelial cells. Such cells could be of use for cytotoxicity testing and for transport studies, 
since sources for adequate models are scarce. One possible approach is cocultivation of stem 
cells with a fully differentiated second cell type. These protocols have often proved to 
influence direction of differentiation [142-146] and even coculture with lung cells has been 
investigated [146, 153, 154]. Hematopoetic stem / progenitor cells, for example, express lung-
epithelial cell specific mRNA and protein when either cultured in lung tissue conditioned 
medium or in coculture with lung tissue [155]. For MSC many publications show an impact 
of coculture on the course of differentiation. When indirectly cocultured with hepatocytes, 
they differentiate to hepatocytes[156]. In indirect coculture with injured cortical tubular renal 
epithelial cells, the developed a tubular epithelial-like phenotype [157]. Also PSC showed to 
be prone to influence of coculture. They were successfully differentiated to cardiomyocytes 
when cocultivated with biopsies of human myocardium. [148]. All things considered 
coculture seemed to be a promising approach for differentiation of human adult stem cells to 
lung epithelial-like cells. Therefore, MSC and PSC were subjected to direct and indirect 
coculture with the lung-epithelial cells lines A549 and Calu-3. 
PSC and MSC displayed nearly no variations in the expression of ZO-1, CTNβ1, AQP 5 and 
EpCAM. Only the bands for AQP 5 in MSC + A549 uncond became slightly stronger and the 
expression of EpCAM in MSC + Calu-3 cond was marginally weaker. Within the expression 
of CDH 1, however, there were distinctive alterations, which were nearly identical for PSC 
and MSC. One difference was the expression of CDH 1 in the stem cell control after 12 days 
of culture. MSC showed a band for this marker at mRNA but not at protein level, whereas 
PSC displayed no expression. The earlier performed characterization (see Chapter  5.3.2.1) 
and the incubation of PSC on ECM (see Chapter  5.3.2.2) showed an increasing expression of 
CDH 1 depending on incubation time. This was possibly due to the growing density of cells 
and the thereby increasing cell-cell contacts (see Chapter  5.3.3).  
Neighborhood of cells of the same cell type, though, is obviously supplemented or even 
outweighed by other factors, namely the presence of a second cell type, either by direct 
contact or just by its conditioned medium. Cultivation of PSC on fixed A549 triggered 
synthesis of CDH 1 after 12 days, while culture on fixed Calu-3 had no comparable effect.  
An influence of the conditioned medium was not observed. Nearly the same expression 
profile was seen for MSC, merely cells on fixed Calu-3 displayed hardly visible bands for this 
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marker. Heterotypic cell contact, therefore, obviously modifies expression of CDH 1 in these 
stem cells.  
Also the type of medium was pivotal when stem cells were cultured in conditioned medium of 
epithelial cells for 21 days on TCP. Only stem cells incubated in unconditioned medium 
displayed bands for CDH 1. As shown before, PSC (see Chapter  5.3.2.2) express CDH 1 after 
21 days of culture and MSC already after 12 days ( 5.5.2.3). Conditioned medium obviously 
suppressed its synthesis. 
For interpreting these results it is important to focus on the role of CDH 1. The family of 
cadherins belongs to cell adhesion molecules which are important for the dynamic regulation 
of adhesive contacts associated with morphogenetic processes. CDH 1 (also named epithelial 
or E-cadherin) is primarily expressed in epithelial cells, where it is associated with the zonula 
adherens of the epithelial junctional complex. [158]. The extracellular region of CDH 1 
connects the cell surface with cadherins on adjacent cells [159]. The intracellular region 
interacts with catenins and other regulatory proteins [160]. CDH 1 is essential to form a tight, 
polarized epithelial cell layer by Ca2+-dependent cell adhesion [161, 162], which can perform 
barrier and transport functions.  
Another function of CDH 1 has to be taken in consideration. It is involved in epithelial to 
mesenchymal transitions (EMT), where differentiated epithelial cells undergo a phenotypic 
conversion that gives rise to the matrix-producing fibroblasts and myofibroblasts. This 
process plays a crucial part in ontogenesis, tissue fibrosis and cancer progression. Loss of 
CDH 1 facilitates EMT, whereas induced expression of CDH 1 can reverse the transformed 
phenotype [163, 164]. In regards to cancer, CDH 1 restricts cell movement by promoting tight 
cell-cell adhesions and therefore reduces metastatic activity [165]. A reduced expression of 
CDH 1 leads to a looser contact to adjacent cells and therefore increases the motility of these 
cells supporting a more invasive cell type [166]. Tumor cell lines and biopsies show lower 
CDH 1 levels compared to normal tissues [167, 168]. Furthermore expression of CDH-1 is 
opposed to presence of plasminogen activating inhibitor I, whose finding correlates with poor 
cancer prognosis. In short CDH 1 is regarded as a tumor suppressor gene [158]. 
Having these properties of CDH 1 in mind, it is obvious, that cell surface and conditioned 
medium of epithelial cancer cells have a reverse influence on the investigated stem cells. 
Conditioned medium of A549 and Calu-3 suppresses synthesis of CDH 1. This may lead to an 
increased motility and even to a more invasive cell type. Which factors are responsible for 
this effect has not been investigated, yet. However, isolation of these mediators could reveal 
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mechanisms of altered signal transduction during cancer development. Further studies should 
therefore try for identification. 
The contrary effect was provoked by the surface of A549. CDH 1 expression was enhanced in 
PSC and maintained in MSC. This could imply an accelerated differentiation into an 
epithelial-like cell type. Prior studies presented influence of A549 on stem cells. ESC 
differentiated to a higher scale to endoderm, when cultured in A549 conditioned medium 
containing activin than with activin alone [153]. And even MSC developed epithelial-like 
characteristics when indirectly cocultured with heat-shocked A549 [169] and likewise in 
direct coculture with CFBE41o- [170]. However, this is the first study to report an influence 
of coculture type on the differentiation:  influence of substrate obviously outweighs the 
impact of conditioned medium during the first 12 days. Further experiments could reveal 
whether this dominance remains during longer cultivation periods. 
One remaining question is whether the CDH 1 suppressing effect of A549 and Calu-3 
conditioned medium is due to the malignant origin of the tumor cell lines. A coculture with 
nontumor-derived primary cells, e.g. HAEpC [66], could help clarification.  
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5.6 RÉSUMÉ 
This part of the thesis explored the potential of PSC and MSC to give rise to endothelial and 
epithelial-like cells. While MSC have already been applied in research for several decades, 
PSC had just been discovered at begin of this thesis. However, none of this cell types had 
before been differentiated to lung epithelial-like cells and only one rather “shaky” protocol 
had been described for the differentiation of MSC into endothelial cells.  
Prior to any differentiation experiment, characterization of PSC revealed a spectrum of 
immanent endothelial, epithelial and stem cell marker expression. Culture on different ECM 
led to minor changes only. Culture by means of Air Interface Culture, however, induced 
significant morphological alterations. Spinning of PSC resulted in three-layered spheroids, 
resembling EBs, that showed signs of spontaneous differentiation.  
None of the multiple approaches for inducing endothelial differentiation were adequate for 
increasing endothelial characteristics of PSC or MSC. However, endothelial potential of PSC 
was already present in untreated cells and was not limited to presence of endothelial markers 
at mRNA and protein level. Additionally, both stem cell types formed spontaneously 
capillary-like structures, which is considered a substantial characteristic of endothelial cells. 
Hence, for triggering the endothelial potential of these stem cells more adequate protocols 
have to be developed. 
Coculture with the epithelial cell lines A549 and Calu-3 led not to a complete epithelial 
differentiation, but to varying expressions of CDH 1. This epithelial marker is also known to 
be decreased in metastatic cells. Only contact to fixed A549 increased expression of CDH 1. 
Incubation with fixed Calu-3 did not provoke any changes, while conditioned medium of both 
lung cancer cell lines suppressed expression of this marker. However, it can be concluded that 
type of coculture and choice of applied epithelial cells influence the direction of 
differentiation of PSC and MSC.  
Both types of stem cells display epithelial- and endothelial potential by expressing 
corresponding lineage markers already endogenously. The endothelial appearance is even 
increased by displaying the endothelial characteristic of building tube-like structures. 
However, protocols tested in this thesis have to be developed further to lead to optimal 
results.  
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6 ZO-1 ISOFORM EXPRESSION IN EPITHELIAL CELL LINES AND STEM 
CELLS. 
 
 
Parts of this section have been published in: 
 
Ciana, A.*, Meier, K.*, Daum, N. Gerbes, S., Veith, M., Lehr, C.-M., Minettei, G., A 
dynamic ratio of the alpha+ and alpha- isoforms of the tight junction protein ZO-1 is 
characteristic of Caco-2 cells and correlates with their degree of differentiation. Cell Biol Int, 
2010. 34(6): p. 669-78.[171] 
 
*equally contributing authors 
 
 
 
6.1 INTRODUCTION  
The animal body consists of four major tissue types: muscle, nerve, connective and epithelial 
tissue. In human 60% of the approximately 200 different cell types are epithelial. All but one 
of these epithelial cells are derived form ectoderm and endoderm during ontogenesis. Solely, 
the endothelium descends from the mesoderm. However, all epithelia have at least one 
function in common. They separate fluids of different composition on either side, acting as 
selective permeable barriers. To achieve this performance epithelial cells need to be sealed 
closely together, which in vertebrates is performed by tight junctions (TJ). These junctions 
combine two functions. First, they create the primary barrier to the diffusion of molecules 
through the paracellular pathway, and, second, maintain cell polarity as a boundary between 
apical and basolateral plasma membrane domains [172, 173]. TJ are located at the apical side, 
are embedded in each of the two adjacent plasma membranes and consist of more than 40 
different protein types. The two major transmembrane proteins in TJ are claudins and 
occludin [174, 175]. They associate with the intracellular peripheral membrane proteins, 
known as zona occludens (ZO) proteins. ZO proteins belong to a family of membrane-
associated guanylate kinase (MAGUK) homologs, which are found in membrane-associated 
proteins acting as adapters and molecular organizers in epithelial and endothelial junctions. 
The three closely related ZO-1, ZO-2 and ZO-3 have so far been identified as members of the 
ZO protein family [176]. For ZO-1 the following is known. It is a ~220 kDa protein found in 
the centre of macromolecular assembly of TJ [177]. Apparently it combines a structural and a 
regulatory role. First, it binds to integral membrane proteins of adjoining cells (occludin, 
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claudins and junction adhesion molecules) and to the cytoskeletal actin [97]. Second, it 
modulates cell proliferation through association with the transcription factor ZONAB [178]. 
The gene encoding for ZO-1 (TJP1) is found in the human genome at chromosome 15 at 
15q13 [179]. Its transcript exists in two alternatively sliced isoforms differing by an internal 
80 amino acids domain known as the α domain [180, 181]. Relative abundance of the two 
isoforms seems to be tissue specific. ZO-1 α- is found as the only or prevailing form in TJ of 
endothelial cells and in highly specialized cells like Sertoli cells or in podoyctes of the renal 
glomeruli. ZO-1 α+ is the dominant isoform in epithelial cells, irrespective of the displayed 
transepithelial electrical resistance (TEER) [180]. However, a relation to junctional plasticity 
was postulated. This is the ability of a junction to open and reseal in response to certain 
stimuli. It was proposed, that α+ isoform was expressed in TJ of high and α- in TJ of low 
plasticity. However, up to present there is no information on possible different functions of 
the two isoforms. 
Since the 1980s the human intestinal cell line Caco-2 has been extensively used as a model of 
the intestinal barrier. The parental cell line was obtained in the 1970s from an 
adenocarcinoma of a 72 year old male Caucasian [182]. The peculiar property of Caco-2 is 
their ability to undergo spontaneous differentiation, after which they display several 
morphological and biochemical characteristics of small intestinal enterocytes [183]. They 
grow in monolayer and display a cylindrical polarized morphology with microvilli on the 
apical side and TJ between adjacent cells. Moreover, they express enzyme activities of the 
small intestine brush boarder (i.e. sucrose-isomaltase, lactase, aminopeptidase N, 
dipeptidylpeptidase IV, alkaline phosphatase). Due to all these properties Caco-2 are widely 
used for biopharmaceutical purposes such as toxicity, transport and proliferation studies and 
are furthermore recognized by the US FDA as a part of bioequivalence waiver process [184]. 
One of the most recent extensive applications of Caco-2 as a test system for biocompatibility 
was during the CellPROM project within the 6th Framework Programme of the European 
Commission [185], during which also this thesis was generated. CellPROM – short for “Cell 
Programming by nanosclaed devices – tried to reprogram cells by non-invasive means on an 
industrial scale. Thereby magnetic carriers have been developed, which allowed the handling 
of cells in a microfluidic system. Several generations of these carriers were tested with Caco-
2 for their biocompatibility before the final model was identified. Not only morphology, cell 
number and proliferation of Caco-2 were investigated but also functional differentiation. This 
was determined by means of activity of the brush border enzyme aminopeptidase N and by 
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expression of the proteins integrin ß1, villin and also ZO-1.  No differential expression of the 
two ZO-1 isoforms was analyzed, though. 
So far, the expression of the two ZO-1 isoforms was mainly investigated for a certain cell 
type or tissue at a given time point at usually quite progressed growth and differentiation 
stages. This static representation of data led to a proposition of an α+/α- ratio, which is 
invariant and even characteristic for the respective cell type [181]. While investigating a 
different issue in the Department of Biochemistry at the University of Pavia, Italy, it was 
found that during cultivation of Caco-2 the amount of expressed ZO-1 isoforms differed 
considerably. This observation was contrary to all other reports published previously. 
Therefore, the institute of Pavia and the Institute of Biopharmaceutics and Pharmaceutical 
Technology, Saarland University, Germany designed a cooperative study. Aim of this study 
was to answer the questions, where this behaviour resulted from, what other parameters it 
correlated with and whether it was peculiar for Caco-2. Dynamic expression of ZO-1 isoforms 
was investigated at mRNA and protein level during in vitro proliferation of cells. Not only 
Caco-2 were analyzed but in total 6 cell types in order to elucidate, whether only Caco-2 
showed this property. Three other epithelial cell lines were chosen, T84 as a further model of 
an intestinal cell line and A549 and Calu-3 representing the lung epithelium. ECV304 were a 
model of an endothelial cell line and PSC (pancreatic stem cells) as primary stem cells 
completed selection of cell types. In Saarbrücken all epithelial cell lines and also PSC were 
investigated for a relationship between ZO-1 isoform expression and cell number / density, 
proliferating activity, TEER value and expression of another TJ protein, namely occludin, 
over a period of 16 culture days. In Pavia additional experiments were performed comprising 
the expression of ZO-1 in ECV304 and the correlation between isoform expression in Caco-2 
and their grade of functional differentiation. Experiments carried out in Saarbrücken are 
explicated extensively in the following Chapter  6.2 Material and Methods and the Results 
( 6.3) part. Results from Pavia are summarized and implicated in the Discussion ( 6.4). 
6.2 MATERIALS AND METHODS 
6.2.1 ROUTINE CELL CULTURE AND BASIC CELL CULTURE DURING EXPERIMENTS 
Cells applied in this study were the colon derived cell lines Caco-2 and T84, the lung derived 
cell lines A549 and Calu-3 and the pancreas derived primary stem cells PSC.  
Caco-2 (ATCC-No: HTB-37) were maintained in RPMI-1640 – High Glucose with L-
Glutamin (RPMI, GIBCO) and supplemented with 10 % FBS (PAA). They were subcultured 
in a ratio of 1:10. 
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T84 (ATCC-No: CCL-248) were maintained in Dulbecco’s modified Eagle’s medium / F12 
(DMEM / F12) supplemented with 5 % FBS (PAA). They were subcultured in a ratio of 1:5. 
A549 (ATCC-No: CCL-185) were maintained in RPMI-1640 - High Glucose with L-
Glutamin (RPMI, GIBCO) supplemented with 10 % FBS (PAA). Subculture ratio was 1:50. 
Calu-3 (ATCC-No: HTB-55) were maintained in RPMI-1640 - High Glucose with L-
Glutamin and without phenolred (PAA) supplemented with 10 % FBS GOLD and 1 mM 
sodium pyruvate (Lonzy, Basel, Switzerland). They were subcultured in a ratio of 1:7.5. 
The adult human stem cells PSC were a generous gift from Fraunhofer Institut St. Ingbert, 
Germany. Cell isolation was described by Kruse et al. in 2004 [1]. All experiments were 
performed with cells from passages 13 to 23 from the clone Cepan 3b. PSC were maintained 
in a primary medium consisting of Dulbecco's modified Eagle's medium - High Glucose with 
L-Glutamin (DMEM, GIBCO Invitrogen; Karlsruhe, Germany) supplemented with 10 % fetal 
bovine serum gold (FBS GOLD), 100 units/ml penicillin and 100 µg/ml streptomycin (all 
from PAA; Pasching, Austria). PSC were seeded at a density of 5 x 105 in T-75 cell culture 
flasks and routinely subcultured at 80 to 90 % confluence. 
All cells were routinely incubated at 37°C in 5 % CO2 and regularly tested for mycoplasm 
infections. Subculturing was performed once and medium was changed three times a week.  
For setup of experiments all cells were seeded at a starting density of 3 x 104 cells/cm2 in 
12-well plates or, for determination of TEER, in Transwell® 12-well permeable supports (all 
from Corning, Schiphol-Rijk, Netherlands). 
6.2.2 CELL NUMBER (CYQUANT AND HOECHST ASSAY) 
A determination of cell number was required for two reasons. First, one possible criterion for 
the expression of different ZO-1 isoforms was the density of cells. Second, cell number was 
needed for the volume calculation of samples for Westernblot (see Chapter  6.2.7). 
This happened by measuring at each time point of cell growth by an assay based on dye 
fluorescence enhancement upon binding to cellular nucleic acids (Figure 25). For all cells but 
Caco-2 (quantification was performed in Pavia by HOECHST assay, see below) CyQuant 
assay (CyQuant Cell Proliferation Assay Kit, Invitrogen, Karlsruhe, Germany) was applied. 
At the first step of cell lysis the protocol was slightly adapted from the manufacturer’s 
manual. Instead of applying repeated freeze and thaw circles cell lysis was induced after 
rinsing with PBS by incubating cells at 37°C for 45 min with 50 % (v/v) CelLytic™-M 
(Sigma-Aldrich, Schnelldorf, Germany) solution in water. Subsequently, provided dye 
solution was added and cells were incubated for 20 min in the dark at RT. Supernatant was 
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then transferred to a 96-well plate and fluorescence was measured at 485 / 535 nm in a 
fluorescence plate reader (Cytofluor II, PerSeptive Biosystems, Wiesbaden, Germany). 
Calibration was performed by including standard DNA in the same microplate as the samples 
to be measured. Already before a conversion factor between DNA amount and cell number of 
the respective cell type had been determined. This was performed by comparing the 
fluorescence of the DNA standard with that of cell lysates obtained from cell suspensions, 
which cell number had been accurately counted. 
 
intact cell cell lysis dye binding to 
nucleic acids
fluorescence
enhancement
 
Figure 25: Schematic drawing of principle of CyQuant assay adopted from the manufacturers manual. 
 
For the samples of Caco-2 cells the HOECHST assay, which is also based on fluorescence 
enhancement after binding to cellular nucleic acids, was performed in Pavia. Adherent cells 
were rinsed with PBS and lysed in the same lysis buffer as used for CyQuant assay at 37°C 
for 45 min. A solution of 5 µg/ml Hoechst 33258 dye (Sigma-Aldrich, Milan, Italy) was 
added, cell lysate resuspended and fluorescence read within 25 min at 360 / 465 nm in a 
microplate reader (GENios Plus, Tecan, Milan, Italy). The dye solution was prepared by step-
wise addition of 1 mg/mL dye stock solution to pre-warmed TNE 2X (20 mM Tris/HCl, 4 M 
NaCl, 2 mM EDTA, pH 7.4), and subsequently diluting TNE with water to the final 1X 
concentration 
6.2.3 CELL PROLIFERATION (BRDU COLORIMETRIC ASSAY)) 
Apart from cell number also the state of proliferation was of possible influence to the 
expression of ZO-1 isoforms. 
For following the proliferation of cells an assay was performed, which exploits the 
incorporation of 5’-Bromo-2’-deoxy-uridine (BrdU) into newly synthesized DNA of 
replicating cells (Fehler! Verweisquelle konnte nicht gefunden werden.). This Cell 
Proliferation ELISA, BrdU (colorimetric) assay (Roche, Basel, Switzerland) was applied 
according to the manufacturer’s manual. In short, a BrdU labeling solution was added to cells 
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for 24 h, before fixing and incubating the cells with anti-BrdU-peroxidase solution. Finally, 
cells were incubated for 15 min with a substrate solution until reaction was terminated by 
adding a stopping solution. Absorbance was then measured at 450 nm (Infinite 200 M 
multimode microplate reader; Tecan, Crailsheim, Germany). 
6.2.4 TEER (TRANSEPITHELIAL ELECTRICAL RESISTANCE) 
A previous publication [180] reported no correlation between the ratio of ZO-1 isoform 
expression and transepithelial electrical resistance (TEER). In order to reexamine this 
circumstance for cells applied in this study, values for TEER were measured with an 
epithelial volt-ohmmeter (EVOM, World Precision Instruments, Berlin, Germany). TEER of 
plain filters was subtracted as background. 
6.2.5 RT-PCR (REVERSE TRANSCRIPTASE- POLYMER CHAIN REACTION)  
For analyzing the gene expression status of the two ZO-1 isoforms in the different cell types 
RT-PCR was performed.  
For all samples but Caco-2 mRNA isolation was performed by means of RNeasy Mini Kit 
(Qiagen, Hilden, Germany). For synthesis of first strand cDNA Omniscript RT Kit (Qiagen) 
was applied. Both protocols were performed according to the manufacturer’s manual. For 
samples of Caco-2 mRNA isolation and CDNA synthesis were performed in Pavia (see 
below). PCR was carried out with Taq PCR Master Mix Kit (Qiagen) in a final volume of 
50 µl containing 25 pmol of each nucleotide primer. For specific amplification of ZO-1, β-
actin (ACTB) and occludin (OCL), Taq PCR Master Mix was supplemented with 25 mM 
MgCl2 to yield a final concentration of 2.5 mM MgCl2 in reaction mixture. PCR of ZO-1 
isoforms was performed with primers flanking the α motif [181] (Table 3), so that 
amplification products of 474 and 234 bp correspond to ZO-1 α+ and ZO-1 α– mRNA, 
respectively. PCR of ACTB resulted in products of 315 bp and for OCL in products of 
294 bp. One PCR cycle was: 94°C for denaturation, 60°C for annealing and 72°C for 
extension, with a total of 40 cycles for ZO-1 and 30 cycles for β-actin. For occludin, the PCR 
cycle was: 95°C for denaturation, 52°C for annealing and 72°C for extension in a total of 
35 cycles. All amplifications were carried out in PTC-200 Peltier Thermal Cycler (MJ 
Research, GMI, Minnesota, USA) (Figure 3). 
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Table 3: Specific primers used for RT-PCR 
Primer name RefSeq Ids Primer sequences Amplicon size [bp] 
ACTB NM_001101 F: 5'- tcctgtggcatccacgaaact-3' R: 5'- gaagcatttgcggtggcaga-3' 315 
OCL  NM_002538 F: 5'- ccgacacaccacacctacac-3' R: 5'- tcgaacatgcatctctccac-3' 294 
ZO-1 (named ZO-1-iso in 
Charter  5) 
NM_175610 
NM_003257 
F: 5'-catagaatagactcccctgg-3' R: 5'-gcttgaggactcgtatctgt-3' 234 
474 
 
Isolation of mRNA from Caco-2 samples was performed in Pavia with 1 ml of TRIzol® 
(Invitrogen, Milan, Italy) for a maximum of 2 x 106 cells. First-strand cDNA was synthesized 
using High-Capacity cDNA Archive Kit (Applied Biosystems, Milan, Italy) according to the 
manufacturer’s manual. 
6.2.6 DENSITOMETRIC ANALYSIS OF RT-PCR DATA 
PCR gels were examined by creating a density plot profile in ImageJ (National Institute of 
Health, USA). All data were corrected for background by subtracting values for an empty lane 
of the same gel. The graph was designed by means of SigmaPlot 10 (Systat Software, Inc., 
Germany) and densitometric intensity was defined by integration of the area under a peak 
corresponding to a band. Since mRNA bands were not for all cell types on the same gel, the 
detection intensity was not constant. A comparison or even ranking of the absolute values 
between the different cell types is therefore not possible (Figure 28). In order to enable at 
least a partial comparison among the cell types all values were related to a reference. This 
reference was calculated for each cell type by adding the values of both isoforms for every 
time point and creating a mean over the total period. This mean was then referred to as 100 % 
(Figure 29). 
6.2.7 WESTERNBLOT 
Since not only the gene expression of the ZO-1 motif is important but even more the presence 
of the protein a Westernblot was performed.  
Sample taking and denaturating of protein was performed for all cells but Caco-2. SDS page 
and the actual blotting were conducted in Pavia (see below). For retrieving samples, adherent 
cells were incubated with 5 mM di-isopropylfluorophosphate in PBS (0.3 ml/cm2) for 5 min 
and subsequently dissolved in 0.5 vol. of SDS-PAGE sample buffer (50 mM Tris/HCl, 5 % 
(w/v) SDS, 35 % (w/v) sucrose, 5 mM EDTA, 200 mM dithiothreitol and 0.01 % 
bromophenol blue, pH 6.8) by repeated pipetting. Sample taking was concluded be 
denturating proteins at 60°C for 15 min.  
In Pavia sample volumes corresponding to 2.0 x 104 cells (for quantification see Chapter 
 6.2.2) were subjected to SDS-PAGE [186] in 8 % acrylamide gels. Sample volumes 
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corresponding to were loaded in each lane. The electrophoretic run was prolonged for 1 h 
after the front dye had reached the bottom of the gel in order to improve the separation of the 
two ZO-1 isoforms. Samples were electrotransferred to a 0.2 µm PVDF membrane, either 
taking the gels as a whole [187] or performing a multistrip Western blotting [188]. PVDF 
membranes were blocked with 20 mM Tris/HCl, 150 mM NaCl, 0.05 % Tween-20, and 5 % 
skimmed milk (w/v), pH 7.4, incubated overnight at 4°C with primary antibody. These 
primary antibodies used were mouse monoclonal anti-ZO-1 (Becton Dickinson, Milan, Italy) 
and rabbit polyclonal anti-occludin (Zymed Laboratories, Invitrogen, Milan, Italy). After 
incubation with the corresponding secondary antibody protein bands were visualized by 
means of ECL kit (Amersham, GE Healthcare, Milan, Italy). ZO-1 isoform ratio was 
calculated after densitometric quantification of protein bands on a digital image of films, 
using the software Scion Image (Scion Corporation, Frederick, MD, USA). 
6.3 RESULTS 
For investigating whether the shifting expression of ZO-1 isoforms is specific only for Caco-2 
or whether it occurs also in other cell lines Caco-2 were compared with the following cell 
types: the epithelial tumor cell lines T84 (colon origin like Caco-2), A549, Calu-3 (both lung 
origin) and the stem cells PSC (primary cells derived from pancreas) (Figure 26). These cells 
types were analyzed in respect to shift of isoform expression at mRNA (Figure 27a, RT-PCR) 
and protein level (Figure 27b, Westernblot) in correlation to cell density (Figure 30a, 
CyQuant), proliferation (Figure 30b and c, BrdU) and TEER value (Figure 30d). In order to 
investigate whether other TJ proteins showed similar changes in expression levels during 
epithelial differentiation mRNA for occludin was also examined (Figure 27a). Culture of 
cells, sample taking for RT-PCR and Westernblot, performance of RT-PCR, CyQuant (cell 
number), BrdU (proliferation) and measurement of TEER were performed in Saarbrücken. 
Pavia accomplished the Westernblots and provided the Caco-2 samples for RT-PCR. 
As shown in Figure 27 amounts of ZO-1 isoforms varied for all cell types during the 
observation period of 16 days. Changes at mRNA level (Figure 27b) were paralleled by 
corresponding shifts at protein level (Figure 27a).  
Since visual judgment of the gels is quite imprecise, methods for a better illustration of 
mRNA results were applied. First, the bands of the gels were transcribed to a densitometric 
plot (Figure 28). Intensification and decrease of a signal is much easier to judge in this 
depiction. However, important to consider is, that mRNA samples for all cell types were not 
run on one identical gel. It is not guaranteed that the used intensification of signal was 
constant. The height of peaks can therefore be compared within the particular cell type but not 
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Figure 26: Morphology of Caco-2, T84, A549, Calu-3 and PSC 2 and 16 days postseeding determined by 
lightmicroscopy.  
 
between the different cell types. For a better quantification and also comparability of data, the 
relative amount of mRNA was defined by calculating the area under the curve of the 
corresponding peak. This value was then related to a mean (see  6.2.6) and displayed as a 
percental value (Figure 29 a-e). Also the α+ /α- ratio was calculated and shown in Figure 29f.  
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From these three visualizations of results several conclusions could be drawn. First of all 
Caco-2 showed the most noticeable change during the observation period. While the total 
amount of ZO-1 was nearly constant, the expression of isoforms underwent an extreme shift. 
The dominating α- isoform of day 2 and 4 (α+/α- = 0.56 and 0.60) decreased during the course 
of time and the initially only marginally expressed α+ isoform increased continuously (α+/α- at 
day 16 = 2.09). The change point in prevalence was on day 7 when both isoforms were 
expressed at nearly identical levels (α+/α- = 0.95). All other epithelial cell lines showed a 
permanent prevailing of α+ over the whole observation period. However, also T84 and Calu-3 
show a similar development in expression of isoforms as Caco-2. In both cell lines α+ isoform 
increased at least slightly (with a major recess at day 4), while α- decreased simultaneously. 
These opposed developments resulted in a slight decrease of total ZO-1 (with a major recess 
at day 4 as seen for the α+ isoform). The α+ /α- ratio for T84 changed from 1.38 to 2.34 (day 4 
= 1.07) and for Calu-3 from 2.04 to 3.44 (day 4 = 2.02). A549 showed a constant increase of 
both isoforms and therefore also of total ZO-1. The α+/α- ratio varied inconsistently between 
3.68 and 5.40 (day 2 = 4.41, day 4 = 5.40, day 7 = 4.59, day 11 = 3.78, day 16 = 3.68). PSC, 
the only not epithelial cell type, showed no major changes in isoform and total ZO-1 
expression nor in α+/α- ratio (variation between day 4 = 0.9 and day 16 = 1.3). 
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Figure 27: Expression of ZO-1 isoforms and occludin in Caco-2, T84, A549, Calu-3 and PSC over a period of 
16 days. Amount of ZO-1 was determined at protein level by means of WesternBlot (a). At mRNA level 
expression of ZO-1 and also of OCL was analyzed by means of RT-PCR.  
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Figure 28: Densitometric plots of ZO-1 isoform RT-PCR bands in Caco-2, T84, A549, Calu-3 and PSC. The 
upper part refers to α+ isoform, the lower to α. Grey value of y-axis is given nondimensional by 
ImageJ. 
 
Thereby, Caco-2 is the only cell type where an inversion of the isoform ratio was observed. 
Even though T84 and Calu-3 showed a similar development of isoforms no ratio turnover 
took place, since amount of α+ was already initially above amount of α-. All other investigated 
epithelial cell lines had this prevailing of α+ isoform in common.  
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Figure 29: Graphic depiction of the change in expression for both isoforms and the total amount of ZO-1 for 
Caco-2 (a), T84 (b), A549 (c), Calu-3 (d) and PSC (e). Figure (f) displays a survey of the ratio of 
α+/α for all cell types in a logarithmic scaling. All values relate to the densitometric intensity as 
defined by calculating area under the curve of the corresponding peaks in Figure 28. 
 
Such distinct changes as seen for ZO-1 were not observed for the other tight junction protein 
investigated, occludin (Figure 27). All epithelial cell lines expressed occludin at mRNA level 
over the whole period of 16 days. A clear increase was shown for Calu-3 only, while all other 
cell lines displayed a constant expression. For PSC no band was detected at all. Therefore, no 
apparent relationship between amount of occludin and ZO-1 isoforms was found. 
After the development in ZO-1 isoform expression for all cell types had been analyzed, the 
question arose whether any correlation to cell number / density, proliferating activity, density 
of cell layer, determined by means of TEER value, was detectable. The observations 
corresponding to these criteria were the following. 
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Figure 30: Over a period of 16 days Caco-2, T84, A549,Calu-3 and PSC were investigated for cell number/cm2 
(a, CyQuant), total cell proliferation (b, BrdU) relative cell proliferation (c) and TEER (d). Graphs 
show the average of three independent experiments and error bars indicate SD. 
 
The number of cells increased strongly for all epithelial cell lines in the beginning of the 
growth period and leveled off from day 7 for A549 and Calu-3 and from day 11 for Caco-2 
and T84 (Figure 30a). Although total proliferation (Figure 30b) increased permanently 
throughout growth of cells, proliferation related to number of cells (Figure 30c) decreased 
drastically after day 2. TEER values for Caco-2 increased up to day 11 and weakened slightly 
thereafter, while Calu-3 displayed a very strong and constant enhancement from day 7 on 
(Figure 30d). A549 and T84 displayed no significant increase in TEER value at all. PSC 
showed no indicative changes in neither cell number nor proliferation nor TEER value 
(Figure 30a-d). Therefore, no obvious correlation between any of these criteria and expression 
of ZO-1 isoforms could be determined.  
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6.4 DISCUSSION 
Previous experiments at the University of Pavia suggested that Caco-2 display a shifting ratio 
of ZO-1 isoforms. This, however, contradicts the accepted opinion in literature, where the 
ratio of ZO-1 isoforms is described as invariant and characteristic for the according cell type 
[181]. In order to investigate whether this observation was reproducible, whether it was 
particular for Caco-2 and what other parameter it correlated to, a cooperative study between 
Pavia and Saarbrücken was designed. In Saarbrücken not only Caco-2 but also the epithelial 
cell lines T84, A549 and Calu-3 and additionally the human primary stem cells PSC were 
investigated for the expression of ZO-1 isoforms over a period of 16 days. Caco-2 were the 
only cell type to show a complete turnover in the ratio of ZO-1 α+/α-. The initially prevailing 
α- diminished over time, while α+ increased to become the dominant isoform. All other 
epithelial cell lines showed a continuously prevailing α+. However, even here the ratio was 
not constant but varied considerably up to a factor of 2. PSC, as the only cells of a non-
epithelial origin, displayed a balanced ratio of the two isoforms varying around 1. For all cells 
the ZO-1 protein expression was paralleled by corresponding bands at mRNA level. Hence, 
the protein expression was already initiated at the transcriptional stage and was not altered in 
the course of translational events. For none of the cell types a correlation was found between 
appearance of ZO-1 isoforms and any of the in parallel investigated factors, cell 
number / density, proliferation, TEER or occludin expression.  
Major parts of these results have been published in 2010 together with the University of Pavia 
[171]. Only the densitometric analysis of mRNA data has been performed later resulting in a 
more precise view of amounts and ratio of ZO-1 isoforms. While the paper assumed that the 
isoform expression for all cells but Caco-2 was rather constant, densitometric analysis showed 
that all epithelial cell lines displayed a varying ratio of α+/α- up to the factor 2. Furthermore, 
the paper suggested a prevailing of α- in PSC. Densitometric analysis revealed that both 
isoforms are found at similar levels.  
However, the publication of Ciana, Meier et al [171] comprised more data on expression of 
ZO-1 isoforms. In addition to the already presented four epithelial cell lines and the primary 
stem cells, also ECV304 as a model for endothelial cells was investigated. The exclusive and 
constant high expression of α- was in accordance to previous publications, which report of a 
solely or predominant occurrence of α- in endothelia [180, 189]. Moreover, the matter was 
pursued, whether different growth surfaces had not only an effect on differentiation level of 
Caco-2, as previously reported [185, 190, 191], but also on isoform ratio shift. In a first 
experiment cells cultured upon permeable polyethylene therephtalate (PET) inserts displayed 
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an isoform expression comparable to cells cultured on polystyrene or glass. In a second 
experiment modified surfaces with nanostructured patterns reduced differentiation, as 
determined by aminopeptidase (APN) activity. This was mirrored by lower α+/α- ratios. This 
proves that indeed there is a correlation between differentiation level and ZO-1 α+/α- ratio in 
Caco-2. Not only the correlation between APN activity and α+/α- ratio during culture on 
nanostructured substrates hints in this direction but also an earlier report, that found little or 
no effect on expression of efflux pump P-gp and carrier mediated transporters for Caco-2 
grown on permeable substrates [192]. This is concordant to the unaltered α+/α- ratio in Caco-2 
upon permeable PET inserts.  
Although both, Caco-2 and also expression of ZO-1 isoforms in various cell lines and tissues, 
have been investigated thoroughly in the past, up to date no time-dependant shift in the α+/α- 
ratio was described. Solely, the predominant or exclusive expression of either isoform has 
been reported. A basic rule said that α+ was the dominant isoform in most epithelia, while α- 
was found prevailing in endothelium [180, 181]. Their difference in function, however, could 
not be identified, yet. The function of ZO-1 in TJ in general is considered as that of a 
junctional organizer. It builds up a connection between the adhesion molecules (occludin and 
claudins) and the cytoskeleton and plasma proteins. It seems not to be essential for the 
construction of a belt-like zona occludens, though, as reported recently [193]. When ZO-1 
biosynthesis in mouse epithelial cell line Eph4 was suppressed, TJ showed a normal 
organization of occludin and claudins and were formed without visible morphological 
changes. However, levels of ZO-2 were up-regulated and levels of cingulin, another scaffold 
protein of TJ, were down-regulated. In a further study Eph4 cells lacking ZO-1, -2 and -3 did 
not build up any TJ [194]. When expressed exogenously, though, both, ZO-1 and ZO-2 were 
able to determine independently whether and where claudins polymerized in epithelial cells. 
Moreover, Pulimeno et al [195] showed, that ZO-1 is essential for recruiting paracingulin to 
TJ. ZO-2 was of no relevance for this process. These data demonstrate that the two MAGUK 
proteins ZO-1 and ZO-2 show a functional redundancy up to some extent, even though each 
protein has its pivotal function.  
ZO-1 is not only found in TJ of epithelial and endothelial cells, but frequently also at other 
places. First of all, it is localized in adherens junctions (AJ), where it is always associated 
with cadherin-mediated cell adhesion. In AJ it is found in non-epithelial cells like cardiac 
muscle cells and fibroblasts but also in epithelial cells, which do not express well developed 
TJ, i.e. hepatocytes [196, 197]. During maturation of epithelial cells ZO-1 is also pivotal for 
the conversion from loose “fibroblastic” AJ to belt like polarized epithelial cells [198]. Other 
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publications report findings of ZO-1 in the nucleus [181]. Here it binds to the ZO-1 associated 
nucleic-acid-binding protein (ZONAB), a Y-box transcription factor [199]. These factors 
interact with DNA and RNA and are involved in transcription, RNA stability and translation 
[200]. And indeed a regulation of proliferation by means of this pathway was found for 
MDCK cells [178].  
When concentrating on the differential expression of the two isoforms, it becomes clear that 
so far no real evidence of the ZO-1 α motif has been found. In epithelial cells both isoforms 
are found to co-localize at membrane level [181], and there are also reports on a co-
localization of α+ with F-actin and of α- with G-actin in testes of guinea pigs [201]. The 
prevailing expression of α- in endothelial cell types was correlated to the junctional plasticity 
of the junction [180], which was defined as “the capacity to actively open and reseal the 
intercellular space or to move within the plane of the plasma membrane during normal 
physiological activity”. A correlation to electrical resistance could not be educed, neither for 
epithelial nor endothelial cell types, since wide ranges for TEER are found in both endothelia 
and epithelia, which express predominantly either isoform. This was also underlined by 
another study, which examined the influence of vascular endothelial growth factor on ZO-1 
isoform expression [189]. The two investigated cell types, vascular endothelial cells and 
retinal pigmented epithelial cells, responded conversely to VEGF, by increasing or decreasing 
expression of always both isoforms. An up-regulation was paralleled by an increase in TEER, 
a down-regulation by a decrease. Since both isoforms were regulated always in parallel, no 
indication of the differential role of the two isoforms was obtained. A similar observation was 
found in the present study. Four different epithelial cell lines and also PSC were investigated 
for the expression of ZO-1 isoforms and a parallel to TEER. No correlation was found, 
however. Neither a correlation to cell density, cell proliferation or occludin expression could 
be detected.  
While the function of the two ZO-1 isoforms in mature cells is thus still open, an important 
role for ZO-1 and its isoforms was also found during ontogenesis. Its function was 
investigated thoroughly for the early mouse embryo [99], where temporal and spatial isoform 
expression was examined at different stages. ZO-1 α+ was detected in oocytes and in all 
preimplantation stages. Transcripts of α- were found not before the late morula phase, but 
always co-localizing with occludin. Hence, expression of α+ was understood as a rather late 
and pivotal step during maturation of functional TJ, ensuring a tight paracellular seal [202]. 
Findings in this thesis of balanced levels of both isoforms in PSC indicate a level of 
maturation, which is to be classified between preimplantation and morula stages. 
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Furthermore, the expression of both isoforms in PSC are in concordance with earlier chapters 
of this thesis ( 5.3,  5.4 and  5.5) [3]. Already in their undifferentiated state PSC expressed 
epithelial and endothelial markers and even showed spontaneous tube formation on a 
semisolid matrix. This is considered as a typical property of endothelial cells [77]. Presence of 
α
-
 therefore underlines the endothelial properties, while findings of α+ underline the epithelial 
predisposition.  
One aim of this study was to investigate whether a shift in isoform expression was unique for 
Caco-2 cells. And although all investigated cell types showed variations of the isoform ratio, 
Caco-2 were the only to display a complete turnover. In comparison to other colon carcinoma 
cell lines Caco-2 exhibit a better morphological and functional enterocytic phenotype. After 
spontaneous differentiation they display microvilli, a polarized barrier and also markers of 
adult enterocytes. It was postulated, that this process is due to a shift from a tumor/adult 
colonic to a fetal phenotype that expresses functions of the small intestine [203, 204]. The 
distinction to the mature enterocyte is explained by an incomplete conversion from the 
proliferative (crypt) to the differentiated (villous) phenotype. This is underlined by analysis of 
gene expression patterns by means of microarrays [113, 205]. Upon formation of cell-cell 
contacts a switch in gene expression programs was observed. Proliferating, non-polarized 
Caco-2 underwent a development to postmitotic polarized cells. While the proliferating cells 
showed a gene pattern similar to that in human colon cancer in vivo, postmitotic Caco-2 
displayed a pattern closely to that of a normal colon tissue. In the course of this transition, 
genes responsible for the evolution of structural and functional characteristics of polarized 
epithelial cells - like the formation of the apical junctional complex and of the brush border 
including expression of the corresponding hydrolases - were up-regulated. APN activity for 
example increased during this transition. This was also found in the course of the extended 
present study. Here this development was also paralleled with a shift in ZO-1 isoform ratio. 
Obviously, the switch from a prevailing α- to a dominant α+ isoform is a further indication of 
the switch in gene expression program, whose timing seems to be innate for Caco-2 [205, 
206].  
In conclusion, this is the first study to report a shift in ZO-1 isoform expression in Caco-2 
cells. Although other investigated epithelial cell lines and also stem cells displayed a varying 
ratio of the two isoforms, Caco-2 were the only cell type to display a complete turnover in 
isoform amounts. No correlation could be found to origin of cells, cell density, proliferating 
activity, TEER value or occludin expression. However, a parallel to the spontaneous 
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differentiation taking place in Caco-2 could be described. Thus, Caco-2 may evolve to a 
useful in vitro model for investigating the function of the ZO-1 α motif.  
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7 SUMMARY AND PERSPECTIVE 
First part of this thesis dealt with directed differentiation of two types of human adult stem 
cells to endothelial and epithelial-like cell types. Adult stem cells offer definite advantages 
over ESC. There is no ethical discussion involved, they display nearly no cancerogenity and 
therapies can be matched by harvesting stem cells directly from the patient. Main application 
areas are in vitro screening of pharmaceutical substances and generation of tissues or organs 
for transplantation. PSC and MSC were the sources of human adult stem cells, which were 
applied in this study. PSC had just been discovered at beginning of this thesis, therefore a use-
oriented characterization was also part of this study. On the contrary, MSC have been 
established in research over the last decades.  
Before differentiation experiments were started, characterization of PSC showed a broad 
immanent expression of endothelial, epithelial and stem cell markers. Cultivation on different 
ECM led to minor differences in marker expression only, AIF provoked obvious 
morphological changes. The influence of AIF on marker expression profile is to be 
investigated in further experiments, for determining whether an epithelial differentiation is 
induced. PSC displayed also the ability to form three-dimensional aggregates after 
centrifugation, which developed a histology of different layers and tissues similar to 
structures known from embryoid bodies. Also here a thorough investigation of the three layers 
would be interesting. Immunocytochemical staining not only for endothelial and epithelial 
markers, but for further lineages, could give insight in structure of these spheroids and their 
spontaneous inner differentiation.  
Protocols for inducing endothelial differentiation comprised combinations of application of 
VEGF and bFGF, incubation in ECGM, growth on FN and serum starvation of stem cells. 
None of the approaches was efficient for increasing endothelial characteristics neither in PSC 
nor in MSC. However, both types of stem cells showed their endothelial potential not only by 
marker expression at mRNA and protein level but also by spontaneous formation of capillary- 
like structures, a substantial endothelial property. Protocols could be improved by application 
of further growth factors, like Insulin-like Growth Factor, coculture with endothelial cells and 
also three-dimensional scaffolds. 
Approaches for inducing epithelial differentiation based on either direct or indirect coculture 
with lung-epithelial cell lines or a combination of both. This cocultivation led to a nearly 
identically altered expression of CDH 1 in both types of stem cells. This protein is not only 
known as an epithelial marker but is also decreased in metastatic cells. In both cell types, 
 7 SUMMARY AND PERSPECTIVE 
83 
direct contact to fixed A549 cells increased expression of CDH 1, while incubation with fixed 
Calu-3 did not. On the other hand, conditioned medium of both lung cancer cell lines 
suppressed expression of this marker. Which mechanisms are involved in this effect has to be 
investigated in further studies. However, it is obvious that type of coculture and choice of 
applied epithelial cells influences the direction of differentiation of PSC and MSC. Possibly, a 
direct coculture with untreated or heat-shocked living cells could increase the endothelial 
specialization. Also type of epithelial cells could be switched and primary cells like hAEpC 
could be applied. Furthermore, combination of AIF and coculture could be efficient. 
Both, PSC and MSC, are possible sources for differentiated cells for usage in in vitro drug 
screening and transplant medicine. They display already endogenously endothelial and 
epithelial markers, which suggests high differentiation ability. Protocols tested in this thesis 
have to be further developed to lead to optimal results.  
 
Second part of this study focused on varying expression of two isoforms α+ and α- of the tight 
junction protein ZO-1. Isoform ratios of this marker were so far considered as constant for a 
certain cell type. However, foregone experiments have shown that during culture of Caco-2 
the ratio of isoform expression varied considerably. Caco-2 are a colon carcinoma cell line 
that exhibits after spontaneous differentiation morphological and biochemical features of 
small intestine and is therefore used as an popular in vitro model of this organ. 
In order to investigate the observation of changing ZO-1 isoform expressions more closely 
not only Caco-2 were examined but also T84, a further intestinal cell model, A549 and Calu-
3, two lung epithelial cell lines, and PSC, as primary stem cells. For all these cell types 
expression of ZO-1 isoforms was related to parameters of cell number, cell density, 
proliferating activity, TEER value and expression of occludin, a further tight junction protein 
for a period of 16  days.  
Caco-2 were the only cell type to show a complete turnover in the ratio of ZO-1 α+/α-. While 
in the beginning expression of α-, the longer isoform prevailed, at later time points expression 
of the short variant α+ came to the fore. During culture of all other epithelial cell lines α+ 
remained the prevailing isoform, even though the ratio here varied also up to factor 2. The 
only non-epithelial cell type, PSC, showed a rather constant isoform ratio varying around 1.  
No correlation of the expressed ZO-1 isoform ratio and any of the other examined parameters 
was found. However, the ratio turnover in Caco-2 was paralleled by their spontaneous 
differentiation, which is peculiar for this cell line. Subsequent studies should investigate 
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isoform expression in further cell types. Examination during differentiation in stem cells 
could shed light on whether a ratio shift is paralleled by a specialization of cells.  
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